Paper Publish Year,DOI,Category (Carbohydrate Mimetic),Mimic of which Carbohydrate,Name of the Carbohydrate Mimetic,Functions,Activity
1999,https://doi.org/10.1002/jccs.199900043,Glycomimetics,trisaccharide,SIALYL LEWIS X,"interaction of sl.e"" tetrasaccharide ligand with a class of calcium-dependent lectins, including E- , P- and L- selectins (Fig. 3).4 The selectin-carbohydrate interaction is involved in intlammatory reactions and, in certain cases, metastasis.",Inflammatory diseases: Anti-sLeX antibodies reduce neutrophil infiltration in ALI and asthma
1999,https://doi.org/10.1002/jccs.199900043,aminoglycoside,β-(1→3)-glucans,"glyco-type 1,3-hydroxyamine",mimetics exhibit strong antibiotic activities.,"Immune modulation: Mimics β-(1→3)-glucans, binds CR3/dectin-1 to stimulate phagocytosis"
2004,doi:10.1016/j.tetasy.2004.11.016,acylaminosugar,N-glycoproteins,"""acetamido derivative of GlcNAc","The acetamido derivative of GlcNAc functions as a simple model of the N-glycoprotein linkage region, used as an acceptor in transglycosylation and reversed hydrolysis catalyzed by β-N-acetylhexosaminidases",Osteoarthritis: Modulates glycosaminoglycan synthesis for joint health
2004,https://doi.org/10.1055/s-2005-868500,glycosides,β-O-glycoside ,b-C-Glycoconjugates,"β-C-Glycoconjugates combine the biological relevance of natural glycans with engineered stability, positioning them as critical tools in drug development, glycobiology research, and multivalent therapeutic design. Their resistance to degradation enables applications ranging from enzyme inhibition to advanced vaccine platforms",Bacterial Infections: Multivalent β-C-glycoconjugates disrupt biofilm formation in E. coli (UTIs) and P. aeruginosa (lung infections) with nanomolar efficacy
2004,https://doi.org/10.1055/s-2005-868500,glycosides,"β-D-allolactose (Galβ1,6Glc)",(1→6)-b-C-Disaccharides,"(1→6)-β-D-disaccharides serve as structural components in polysaccharides, metabolic intermediates, and cell surface markers, with their β-linkage conferring enzymatic resistance, branching properties, and biological recognition roles, making them crucial in glycobiology and prebiotic functions.",Autoimmune Disorders: GlcCer-anti-GlcCer immune complexes in Gaucher disease are mitigated by β-C-glycolipid analogs
2004,https://doi.org/10.1055/s-2005-868500,glycosides,β-linked glycosphingolipids,b-C-Ceramide Analog,"β-C-Ceramide analogs exploit ceramide’s apoptotic signaling while addressing limitations of natural ceramides. Their β-configuration and tailored substituents enhance mitochondrial targeting, enzyme modulation, and antimicrobial effects, positioning them as versatile agents in oncology and infectious disease.",Antimicrobial Therapy: ω-Azido-C6-ceramide kills Neisseria meningitidis and N. gonorrhoeae within 2 hours (MBC = 4 µg/ml)
2004,https://doi.org/10.1055/s-2005-868500,glycosides, β-galactose,b-C-Glycoglycerolipids,"β-C-Glycoglycerolipids are specialized glycolipids characterized by a β-configured carbon-glycosidic bond between carbohydrates and glycerol-based lipids. Their functions span structural, metabolic, and therapeutic roles",Autoimmune Disorders: GlcCer-anti-GlcCer immune complexes in Gaucher disease are mitigated by β-C-glycolipid analogs
2004,https://doi.org/10.1055/s-2005-868500,glycosides,β-linked O-tetrasaccharides,b-C-Tetrasaccharide,"β-C-Tetrasaccharides are synthetic carbohydrate analogs where the glycosidic oxygen is replaced by a carbon atom, forming a stable C–C bond. This structural modification enhances their resistance to enzymatic degradation while retaining biological activity. Their functions span immune modulation, neural development, and cellular signaling","Type 2 Diabetes:C-Trisaccharides (e.g., N-Trisaccharide from Cucumis prophetarum) reduce hyperglycemia by modulating insulin secretion and carbohydrate metabolism enzymes"
2004,https://doi.org/10.1055/s-2005-868500,glycosides,O-linked trisaccharides,C-trisaccharides,C-trisaccharides (carba-trisaccharides) are synthetic analogs of natural trisaccharides where the glycosidic oxygen is replaced by a methylene group,"Type 2 Diabetes:C-Trisaccharides (e.g., N-Trisaccharide from Cucumis prophetarum) reduce hyperglycemia by modulating insulin secretion and carbohydrate metabolism enzymes"
2004,https://doi.org/10.1055/s-2005-868500,glycosides,glucose,phenolic glycoside mimics,"Phenolic glycoside mimics are engineered compounds designed to replicate the bioactive properties of natural phenolic glycosides while overcoming limitations like enzymatic instability and poor bioavailability. Their functions span therapeutic applications, antioxidant activity, and targeted drug delivery, leveraging structural modifications such as stable C–C linkages or optimized glycosylation patterns","Cancer: Oxoflavidin (phenolic derivative) induces apoptosis in breast cancer cells (MDA-MB-231, IC₅₀ = 26.26 µM) via caspase-3/9 activation"
2005,https://doi.org/10.1186/1860-5397-1-12,glycosidases, glucose,1-deoxynojirimycin (DNJ) family,"its derivatives miglustat (N-nBu DNJ, Zavesa®) and miglitol (N-hydroxethyl DNJ, Glyset® or Diastabol®) have already found therapeutic applica tions in Gaucher's disease [11] and type 2 (non-insulino dependant mellitus) diabetes,","Diabetes: Inhibits α-glucosidase, reducing postprandial hyperglycemia"
2005, https://doi.org/10.1002/chem.200500025,glycosides,natural saccharides,O-galactosyl aldoximes,O-galactosyl aldoximes function as potent inhibitors of galectin-3,Antiviral/Enzyme inhibition: Potential glycosidase inhibitors
2005,https://doi.org/10.1016/j.bmc.2005.06.059,Modified Glycosides,"Neu5Ac2en, which is a sialic acid derivative","β-O-glycosides of 4,5-unsaturated 2-acetamido-D-glucuronic acid","The function of β-O-glycosides of 4,5-unsaturated 2-acetamido-D-glucuronic acid is to act as mimetics and inhibitors of influenza virus sialidase",Mucopolysaccharidoses/Cancer: Disrupts glycosaminoglycan pathways
2006,https://doi.org/10.1016/j.tet.2006.05.080, glycosidases,glucose,1-cyano-2-phthalimidederivative,"1-Cyano-2-phthalimidederivatives are versatile compounds with a wide range of applications. They are primarily used as intermediates in organic synthesis, particularly in the preparation of various pharmaceuticals, agrochemicals, and dyes2. These derivatives exhibit significant biological activities, including anticancer, antibacterial, anti-inflammatory, and antifungal properties",Cancer Phthalimide derivatives like thalidomide and lenalidomide are used for multiple myeloma and autoimmune diseases
2006,https://doi.org/10.1016/j.tet.2006.05.080, glycosidases,D-glucuronic acid,methyl D-glycero D-gulo-hepturonate,"Methyl D-glycero-D-gulo-hepturonate functions primarily as a synthetic intermediate in carbohydrate chemistry, particularly for constructing complex glycomimetics and glycosidic linkages.",Metabolic disorders: Studied for glucose metabolism modulation but showed limited efficacy compared to D-mannoheptulose
2006,https://doi.org/10.2174/138620706778249703,glycosidases,aglycon moiety,Tetrahydropyridoimidazole,"Tetrahydropyridoimidazole is a heterocyclic scaffold with diverse pharmacological functions, primarily in anticancer therapy, antimicrobial action, and ion channel modulation. Its biological activity stems from structural interactions with key cellular targets, modulated by substituents and stereochemistry.",Cancer: Targets EGFR mutants in non-small cell lung cancer (NSCLC)
2006,https://doi.org/10.1080/07328300600733020,glycoproteins,cyclic peptide cRGDFV,"vitronectins, avb3",a class of extracellular proteins that facilitate cell-cell recognition,"Cancer/Angiogenesis: Inhibitors (e.g., cilengitide) target tumor vasculature and metastasis"
2006,https://doi.org/10.1074/jbc.M604137200,carbohydrate mimetic peptides,mannose,RYRY (also known as D002),serum of D002 immunized mice was able to suppress the binding of HIV gp120 to human dendritic cells,Gastroesophageal reflux disease (GERD): Proton pump inhibitor (rabeprazole) + prokinetic (domperidone) combination
2006,https://doi.org/10.1016/j.carres.2006.01.024,glycomimetics,mannose,nonavalent mannoside,"The function of nonavalent mannoside clusters is to serve as inhibitors of type 1 fimbriae-mediated bacterial adhesion, specifically targeting mannose-specific bacterial adhesion","Bacterial infections: Blocks FimH adhesion in E. coli (e.g., urinary tract infections"
2006,doi:10.2174/157017906778699530,glucopyranose,cyclopeptide tachykinin NK-2 antagonist,2-deoxy-2-thio-D-glucopyranose,2-deoxy-2-thio-D-glucopyranose is designed as a mimic of the cyclopeptide tachykinin NK-2 antagonist,Antiviral/Diabetes: Thiosugar analog with potential for α-glucosidase inhibition
2006,https://doi.org/10.1002/ana.20948,glycosidases,Glycosaminoglycan,(3-Sulfoglucuronyl β1-3 galactoside),"The 3-sulfoglucuronyl β1-3 galactoside, known as the HNK-1 epitope, is associated with myelin profiles of motor axons but not of sensory axons in both intact and regenerating femoral nerves of mice. It has been suggested that the expression of this glycan enhances neurite outgrowth of motor neurons in vitro, although its beneficial effects on nerve regeneration in vivo have not yet been demonstrate","Autoimmune Neuropathies:Targets in Guillain-Barré syndrome and anti-MAG neuropathy. SGGLs on peripheral nerves are recognized by autoantibodies, leading to demyelination"
2006,https://doi.org/10.1021/jo051989g,carbasugar,cyclooctane polyols and glycomimetic,cyclooctadienone (+)-6,"Cyclooctadienone (+)-6 serves as a pivotal compound in the synthesis of enantiopure cyclooctane polyols and glycomimetics. It is derived from D-arabinose and D-glucose through a series of transformations, including zirconocene-promoted ring contraction and [3.3] sigmatropic rearrangement. This compound provides a platform for the synthesis of stereoisomeric cyclooctane-1,2,3-triols and the pentahydroxy derivative, as well as facilitating the generation of glycomimetics",NA
2006,https://doi.org/10.1021/jo051989g,carbasugar,pyranose,"cyclooctane-1,2,3-triols",Glycosidase inhibitors,Explored as intermediates for glycoconjugates with potential antiviral/anticancer activity.
2006,https://doi.org/10.1016/j.tet.2006.05.080,Miscellaneous,D-glucosamine,b(1/2)-amide-linked oligomer,"The ( \beta (1/2) )-amide-linked oligomer is part of a new class of carbohydrate mimetics that are resistant to glycosidases. These oligomers have been investigated for their biological activities, such as anti-HIV activity and inhibition of sialyl Lewis x-mediated cell adhesion. The O-sulfated oligomers effectively inhibited HIV infection, sialyl Lewis x-mediated cell adhesion, and heparanase activity in a linkage-specific manner. Therefore, these molecules have potential applications as drugs that block protein–protein interactions and inhibit enzyme catalysis. Additionally, the ( \beta (1/2) )-linked oligomer forms a rigid secondary structure, mimicking a folding ( \beta )-peptide, which makes it interesting as a tool for mimicking native peptide and protein structures","Antimicrobial Therapy:Linear β(1→2)-linked oligomers (e.g., RNG/DNG analogs) mimic nucleic acids, resisting nuclease degradation and enhancing membrane permeability for antisense therapies"
2006,https://doi.org/10.1016/j.tet.2006.05.080,Miscellaneous,D- glucose,b(1/3)-amide-linked oligomer,"The ( \beta (1/3) )-amide-linked oligomer is part of a new class of carbohydrate mimetics that are resistant to glycosidases. These oligomers have been investigated for their biological activities, such as anti-HIV activity and inhibition of sialyl Lewis x-mediated cell adhesion. The O-sulfated oligomers effectively inhibited HIV infection, sialyl Lewis x-mediated cell adhesion, and heparanase activity in a linkage-specific manner. Therefore, these molecules have potential applications as drugs that block protein–protein interactions and inhibit enzyme catalysis","Antimicrobial Therapy:Linear β(1→2)-linked oligomers (e.g., RNG/DNG analogs) mimic nucleic acids, resisting nuclease degradation and enhancing membrane permeability for antisense therapies"
2006,https://doi.org/10.1016/j.tet.2006.05.080,Miscellaneous,D-galactose,b(1/4)-amide-linked oligomer,"The ( \beta (1/4) )-amide-linked oligomer is part of a new class of carbohydrate mimetics that are resistant to glycosidases. These oligomers have been investigated for their biological activities, such as anti-HIV activity and inhibition of sialyl Lewis x-mediated cell adhesion. The O-sulfated oligomers effectively inhibited HIV infection, sialyl Lewis x-mediated cell adhesion, and heparanase activity in a linkage-specific manner. Therefore, these molecules have potential applications as drugs that block protein–protein interactions and inhibit enzyme catalysis","Alzheimer’s Disease (AD):Multi-target ligands (MTDLs) combining β-sheet-breaking motifs (e.g., benzamide-based oligomers) inhibit Aβ aggregation, chelate metal ions (Zn²⁺, Cu²⁺), and modulate enzymes like acetylcholinesterase (AChE)"
2006,https://doi.org/10.1016/j.tet.2006.05.080,Miscellaneous,D- glucose,b(1/6)-amide-linked oligomer,"The ( \beta (1/6) )-amide-linked oligomer is part of a new class of carbohydrate mimetics that are resistant to glycosidases. These oligomers have been investigated for their biological activities, such as anti-HIV activity and inhibition of sialyl Lewis x-mediated cell adhesion. The O-sulfated oligomers effectively inhibited HIV infection, sialyl Lewis x-mediated cell adhesion, and heparanase activity in a linkage-specific manner. Therefore, these molecules have potential applications as drugs that block protein–protein interactions and inhibit enzyme catalysis","Cancer Immunotherapy:(1→6)-β-glucose-branched poly-amido-saccharides (PASs) mimic β-glucans, stimulating macrophage polarization and enhancing antitumor immunity."
2006,https://doi.org/10.1016/j.tet.2006.05.080,glycosides,O-glycoside ,S-glycosides,"S-Glycosides serve as robust tools in glycan synthesis and enzyme inhibition studies, leveraging their chemical stability and stereochemical control. While therapeutic applications are emerging, their resistance to degradation positions them as promising candidates for drug development and targeted delivery systems.","Cancer: Compound S-2 (β-D-xylopyranosyl derivative) showed moderate cytotoxicity against lung carcinoma (A-549 cells, IC₅₀ = 74 µM) by inducing apoptosis"
2006,https://doi.org/10.1016/j.tet.2006.05.080,Miscellaneous,monosaccharides,pseudosugar cycloalkane,Pseudosugar cycloalkanes (carbasugars) are carbocyclic analogs of natural sugars where the furanose/pyranose oxygen is replaced with a methylene group. These compounds exhibit specialized biological functions due to their structural mimicry of carbohydrates while offering enhanced metabolic stability.,"Diabetes: Acarbose (pseudo-tetrasaccharide) slows carbohydrate digestion, managing type 2 diabetes"
2006,https://doi.org/10.1016/j.tet.2006.05.080,Miscellaneous,D- glucose,Tetrameric carbopeptoids,"Tetrameric carbopeptoids are designed as carbohydrate mimics with amide linkages replacing glycosidic bonds. They are resistant to glycosidases and exhibit interesting biological activities. Specifically, some O-sulfated oligomers of these carbopeptoids have been found to effectively inhibit HIV infection, sialyl Lewis x-mediated cell adhesion, and heparanase activity in a linkage-specific manner. Additionally, they have potential as peptide foldamers due to their ability to form rigid secondary structures, such as a 16-helix form, mimicking β-peptide","Drug-Resistant TB: Meropenem (β-lactam) inhibits D,D-carboxypeptidase activity in Mycobacterium tuberculosis, synergizing with clavulanate"
2007,https://doi.org/10.1055/s-2007-984907,Imino Sugar Mimetics,hexose sugars,Enantiopure aminopyrans,Enantiopure aminopyrans are regarded as carbohydrate mimetics and serve as building blocks for the synthesis of novel enantiopure amino acids with a carbohydrate-like backbone. They are used to generate a wide range of highly functionalized and diverse compounds with potential biological activity,"Anti-inflammatory Diseases: Aminopyrans derived from 1,2-oxazines (e.g., compounds 24, 28) act as carbohydrate mimetics and inhibit L- and P-selectins, proteins involved in inflammation. They show potential for treating inflammatory conditions like arthritis and vascular inflammation"
2007,https://doi.org/10.1055/s-2007-984907,Triazole-Linked Mimetics,D-xylose,Triazoles,Enantiopure aminopyrans are regarded as carbohydrate mimetics and serve as building blocks for the synthesis of novel enantiopure amino acids with a carbohydrate-like backbone. They are used to generate a wide range of highly functionalized and diverse compounds with potential biological activity,"Invasive Fungal Diseases (IFDs): Mold-active triazoles (e.g., voriconazole, posaconazole, isavuconazole) are used for prophylaxis and treatment of fungal infections like aspergillosis and candidiasis in immunocompromised patients"
2007,https://doi.org/10.1016/j.vaccine.2007.01.072,Carbohydrate Mimetic Peptides (CMPs),LeY antigen,CMP 106 (H-GGIYWRYDIYWRYDIYWRYD)8-MAP,effective in vivo in prophylactic vaccination followed by challenge with Meth-A tumor cells,"Myasthenia Gravis (MG):These antigen-specific immune therapies target autoreactive T and B cells against acetylcholine receptors (AChR) in MG. They aim to induce immune tolerance, potentially halting disease progression by reprogramming pathogenic immune responses"
2007,https://doi.org/10.1016/j.vaccine.2007.01.072,Carbohydrate Mimetic Peptides (CMPs),LeY antigen,CMP 107 (H-GGIYYRYDIYYRYDIYYRYD)8-MAP,"CMP 107 is a rationally designed chaperone-disrupting peptide leveraging repetitive tyrosine/arginine motifs in a MAP scaffold to inhibit Hsp90/Cdc37 or Hsp70-client interactions. Its function aligns with emerging strategies to destabilize oncogenic proteins by targeting chaperone systems, offering potential for cancer therapeutics with reduced off-target effects.","Myasthenia Gravis (MG):These antigen-specific immune therapies target autoreactive T and B cells against acetylcholine receptors (AChR) in MG. They aim to induce immune tolerance, potentially halting disease progression by reprogramming pathogenic immune responses"
2007,https://doi.org/10.2174/187152507781058663,BIMOSIAMOSE,tetrasaccharide sialyl Lewis x (sLeˣ,TBC1269,inhibited all three selectins to different degrees and decreased the binding of neutrophils and eosinophils to P-selectin both statically and dynamically,Asthma (Phase II trials)
2007,https://doi.org/10.2174/187152507781058663,Oligomers,heparin,SR123781A,as also proved to be promising,Venous thromboembolism (Phase III trials
2007,https://doi.org/10.1002/chem.200700787,Oligomannoside mimetic,trimannoside,"Methyl 3,6-di-O-(3-{a-d-mannopyranosyloxy}-propyl)-a-d-mannopyranoside",Mimics oligosaccharides for inhibiting mannose-specific bacterial adhesion,Urinary tract infections (UTIs): Inhibit E. coli binding to urothelial cells
2007,https://doi.org/10.1002/chem.200700787,Oligomannoside mimetic,α-mannosylated carbohydrates,"Methyl 3,6-di-O-(3-{3,6-di-O-[3-(a-d-mannopyranosyloxy)-propyl]-a-dmannopyranosyloxy}-propyl)-a-d-mannopyranoside",Mimics oligosaccharides for inhibiting mannose-specific bacterial adhesion,Urinary tract infections (UTIs): Inhibit E. coli binding to urothelial cells
2007,https://doi.org/10.1002/chem.200700787,Oligomannoside mimetic,trimannose core (Manα1-3[Manα1-6]Man),"Methyl 3,6-di-O-(3-{3,6-di-O-[6-a-d-mannopyranosyloxy)-4-thiahexyl]-ad-mannopyranosyloxy}-propyl)-a-d-mannopyranoside",Mimics oligosaccharides for inhibiting mannose-specific bacterial adhesion,Urinary tract infections (UTIs): Inhibit E. coli binding to urothelial cells
2007,https://doi.org/10.1002/chem.200700787,Oligomannoside mimetic,α-mannosylated carbohydrates,"Methyl 3,6-di-O-(6-{a-d-mannopyranosyloxy}-4-thiahexyl)-a-d-mannopyranoside",Mimics oligosaccharides for inhibiting mannose-specific bacterial adhesion,Urinary tract infections (UTIs): Inhibit E. coli binding to urothelial cells
2007,https://doi.org/10.1002/chem.200700787,Oligomannoside mimetic,α(1→3)/α(1→6)-linked trimannose,"Methyl 3,6-di-O-(6-{3,6-di-O-[6-(a-d-mannopyranosyloxy)-4-thiahexyl]- a-d-mannopyranosyloxy}-4-thiahexyl)-a-d-mannopyranoside",Mimics oligosaccharides for inhibiting mannose-specific bacterial adhesion,Urinary tract infections (UTIs): Inhibit E. coli binding to urothelial cells
2007,https://doi.org/10.1002/chem.200700787,Oligomannoside mimetic,α-mannose glycans,"Methyl 3,6-di-O-(6-{3,6-di-O-[6-(a-d-mannopyranosyloxy)-4,4-dioxo-4- thiahexyl]-a-d-mannopyranosyloxy}-4,4-dioxo-4-thiahexyl)-a-d-mannopyranoside",Mimics oligosaccharides for inhibiting mannose-specific bacterial adhesion,Urinary tract infections (UTIs): Inhibit E. coli binding to urothelial cells
2007,DOIhttps://doi.org/10.1039/B700034K,glycosaminoglycan,heparin,PI88,"under phase II clinical trials to treat herpes simplex viral infections,",Hepatocellular carcinoma (Phase III trials)
2007,https://doi.org/10.2174/138161207779313678,peptide,mannose,YRY – the peptide 911,inhibit binding of gp120 to dendritic cells,HIV-1 Infection:Mimics HIV gp120 glycans to elicit cross-reactive antibodies. Used in vaccine development to neutralize viral entry and enhance immune recognition
2007,https://doi.org/10.2174/138161207779313678,cyclic form,mannose,YRY –cyclic form D002,inhibit binding of gp120 to dendritic cells,HIV-1 Infection:Mimics HIV gp120 glycans to elicit cross-reactive antibodies. Used in vaccine development to neutralize viral entry and enhance immune recognition
2007,https://doi.org/10.2174/138161207779313678,cyclic peptide,3-sulfoglucuronyl β1-3-galactoside,D002 (RGGLCYCRYRYCVCGR),mimic based on the YRY motif,"Antimicrobial Therapy:Disrupts bacterial membranes (e.g., Pseudomonas aeruginosa) via amphipathic design, reducing biofilm formation"
2007,https://doi.org/10.2174/138161207779313678,linear,sialylated or sulfated carbohydrate epitopes,912 (YRYRYGRYRSGS),mimics based on the YRY motif,UTIs: Prevents E. coli biofilm formation
2007,https://doi.org/10.2174/138161207779313678,motif,sulfated glycosaminoglycans (GAGs),[KLV]CC[VERP],template specific carbohydrate mimic,"Alzheimer’s Disease:Targets amyloid-beta (Aβ) aggregation (KLVFF motif) and vascular dysfunction (VERP sequence). Inhibits Aβ oligomerization and neurotoxicity, similar to tramiprosate (Alzhemed)"
2007,https://doi.org/10.1016/j.carres.2007.03.012,Amido-based mimetic,β-Galactose,"1-Deoxy-1-(3,5-dimethoxybenzamido)-β-D-mannopyranose",Galectin inhibitor,"Urinary Tract Infections (UTIs):Inhibits FimH-mediated bacterial adhesion in E. coli, preventing bladder colonization"
2007,https://doi.org/10.1016/j.carres.2007.03.012,Amido-based mimetic,β-Galactose,1-Deoxy-1-(2-naphthamido)-β-D-mannopyranose,Galectin inhibitor,"Urinary Tract Infections (UTIs):Inhibits FimH-mediated bacterial adhesion in E. coli, preventing bladder colonization"
2007,https://doi.org/10.1016/j.carres.2007.03.012,Amido-based mimetic,β-Galactose,"1-Deoxy-1-[4-methoxycarbonyl-1H-(1,2,3)-triazol-1-yl]-β-D-mannopyranose",Galectin inhibitor,"Urinary Tract Infections (UTIs):Inhibits FimH-mediated bacterial adhesion in E. coli, preventing bladder colonization"
2007,https://doi.org/10.1016/j.carres.2007.03.012,Amido-based mimetic,β-Galactose,"1-Deoxy-1-[4-methylaminocarbonyl-1H-(1,2,3)-triazol-1-yl]-β-D-mannopyranose",Galectin inhibitor,"Urinary Tract Infections (UTIs):Inhibits FimH-mediated bacterial adhesion in E. coli, preventing bladder colonization"
2007,https://doi.org/10.1016/j.carres.2007.03.012,Amido-based mimetic,β-Galactose,"1-Deoxy-1-[4-ethylaminocarbonyl-1H-(1,2,3)-triazol-1-yl]-β-D-mannopyranose",Galectin inhibitor,"Urinary Tract Infections (UTIs):Inhibits FimH-mediated bacterial adhesion in E. coli, preventing bladder colonization"
2007,https://doi.org/10.1016/j.carres.2007.03.012,Amido-based mimetic,β-Galactose,"1-Deoxy-1-[4-propylaminocarbonyl-1H-(1,2,3)-triazol-1-yl]-β-D-mannopyranose",Galectin inhibitor,"Urinary Tract Infections (UTIs):Inhibits FimH-mediated bacterial adhesion in E. coli, preventing bladder colonization"
2007,https://doi.org/10.1016/j.carres.2007.03.012,Amido-based mimetic,β-Galactose,"1-[4-Butylaminocarbonyl-1H-(1,2,3)-triazol-1-yl]-1-deoxy-β-D-mannopyranose",Galectin inhibitor,"Urinary Tract Infections (UTIs):Inhibits FimH-mediated bacterial adhesion in E. coli, preventing bladder colonization"
2007,https://doi.org/10.1016/j.carres.2007.03.012,Amido-based mimetic,β-Galactose,"1-Deoxy-1-[4-(2-Hydroxypropyl)-aminocarbonyl-1H-(1,2,3)-triazol-1-yl]-β-D-mannopyranose",Galectin inhibitor,"Urinary Tract Infections (UTIs):Inhibits FimH-mediated bacterial adhesion in E. coli, preventing bladder colonization"
2007,https://doi.org/10.1016/j.carres.2007.03.012,Amido-based mimetic,β-Galactose,"1-[4-Benzylaminocarbonyl-1H-(1,2,3)-triazol-1-yl]-1-deoxy-β-D-mannopyranose",Galectin inhibitor,"Urinary Tract Infections (UTIs):Inhibits FimH-mediated bacterial adhesion in E. coli, preventing bladder colonization"
2007,https://doi.org/10.1021/ja067819i,Synthetic Glycopolymer,Mucin,poly(MVK),Rigid polymer backbone for structural mimicry,"Mevalonate Kinase Deficiency (MKD):MVK polymers may modulate the mevalonate pathway, addressing inflammation in rare autoinflammatory disorders"
2007,https://doi.org/10.1021/ja067819i,Synthetic Glycopolymer,Mucin,co-poly(MVK/DAPA),Enhanced backbone rigidity in synthetic membranes,"Mevalonate Kinase Deficiency (MKD):MVK polymers may modulate the mevalonate pathway, addressing inflammation in rare autoinflammatory disorders"
2007,https://doi.org/10.1021/ja067819i,Synthetic Glycopolymer,Mucin,co-poly(IMK/DAPA),Mimics extended mucin structure in cell models,"Mevalonate Kinase Deficiency (MKD):MVK polymers may modulate the mevalonate pathway, addressing inflammation in rare autoinflammatory disorders"
2007,https://doi.org/10.1093/glycob/cwm020,Polymer mimetic,GM3,GM3-p (GM3 mimetic polymer),Inhibits NIH3T3 cell proliferation,Potential use in metastatic cancers
2007,https://doi.org/10.1093/glycob/cwm020,Polymer mimetic,LacCer,LacCer-p (LacCer mimetic polymer),"Lactosylceramide mimetic polymer (LacCer-p) is a synthetic analog designed to replicate the structure of natural lactosylceramide (LacCer), a glycosphingolipid involved in membrane organization and signaling.",Potential use in metastatic cancers
2007,https://doi.org/10.1021/bc700212b,Liposome,sialyl Lewis X (sLeX),SuLea-PEG-DSPE,may be used as nanocarriers to target activated platelets for drug delivery to the injury sites of cardiovascular diseases,Cardiovascular Diseases:PEG-DSPE-based nanocarriers are employed in delivering drugs for thrombosis and cardiovascular conditions due to prolonged circulation times and reduced systemic toxicity
2007,https://doi.org/10.1021/bc700212b,Liposome,sialyl Lewis X (sLeX),SuLea-DSGA,Used as a glycolipid without a PEG spacer for initial targeting studies,Cardiovascular Diseases:PEG-DSPE-based nanocarriers are employed in delivering drugs for thrombosis and cardiovascular conditions due to prolonged circulation times and reduced systemic toxicity
2007,https://doi.org/10.1021/bc700212b,Liposome,sialyl Lewis X (sLeX),PEG-DSPE,"Prolongs circulation time, provides steric stability",Cardiovascular Diseases:PEG-DSPE-based nanocarriers are employed in delivering drugs for thrombosis and cardiovascular conditions due to prolonged circulation times and reduced systemic toxicity
2007,https://doi.org/10.1111/j.1742-1241.2007.01437.x,GLP-1 mimetic,GLP-1,exenatide,Subcutaneous injection for type II diabetes,Type II Diabetes:A GLP-1 receptor agonist that improves insulin secretion and reduces blood glucose levels.
2007,https://doi.org/10.1111/j.1742-1241.2007.01437.x,GLP-1 mimetic,GLP-1,liraglutide,Once daily dosing for type II diabetes,Obesity & Type II Diabetes:Enhances insulin sensitivity while promoting weight loss
2008,https://doi.org/10.1007/BFb0119258,Heparinoid Mimetic,heparinoid,Aprosulate,"underwent phase I clinical trials. Whereas the drug was well tolerated and efficacious, it was associated with increased transaminase levels","A synthetic glycosaminoglycan with anticoagulant properties. Prolongs activated partial thromboplastin time (aPTT) and inhibits platelet-induced thrombin generation, showing promise for thromboprophylaxis"
2008,https://doi.org/10.1007/BFb0119258,Heparinoid Mimetic,heparin,Sucrose octasulfate,"The basic aluminium salt of sucrose octasulfate, which is used as a drug (Sucralfate, Carafate) for the treatment of duodenal ulcers was claimed to exert part of its activity through the stabilization of FGF in stomach","Gastrointestinal Disorders:Protects against reflux esophagitis by forming a mucosal barrier, reducing acid-induced damage"
2008,https://doi.org/10.1007/BFb0119258,Heparinoid Mimetic,heparinoid,"6H-β-maltosyl-(1→4)-α,α-trehalose",high antiproliferative activity,"Tuberculosis (TB):Targets trehalose utilization pathways (TUPs) in Mycobacterium tuberculosis. Inhibits enzymes like OtsA/B2, critical for cell wall glycolipid synthesis"
2008,https://doi.org/10.1007/BFb0119258,Non-Carbohydrate Compounds,heparinoid,Suramin,"used as a drug to treat African trypanosomiasis and onchocerciasis (a filarial infection), it was also tested in a number of other
indications including adrenocortical carcinomas and AIDS",Prostate cancer (chemosensitizer with docetaxel)
2008,https://doi.org/10.1007/BFb0119258,Non-Carbohydrate Compounds,heparinoid,"1,3-propanediol disulfate",reduced inflammation-associated amyloid progression in vivo after oral administration which may be relevant to the treatment of Alzheimer's disease,Metabolic disorders: Enhances polyunsaturated fatty acid (PUFA) production in Schizochytrium for dietary supplementation
2008,https://doi.org/10.1128/CVI.00050-08,peptide mimic,Shigella flexneri Y O polysaccharide (PS),MDWNMHAA,"functional mimicry and a bound peptide conformation that was not represented significantly in the free-ligand ensemble; mice were
immunized using MDWNMHAA-TT as the immunogen, it showed anti-peptide antibody (immunoglobulin G [IgG]) titers that increased after being boosted, improve the immunogenicity of the carbohydrate-mimetic peptide
and confirming the antigenic mimicry",NA
2008,https://doi.org/10.2174/187152008783330851,Iminosugars,N-acetyl-D-glucosamine,"2-Acetamido-1,5-imino-1,2,5-trideoxy-D-glucitol",potent inhibitor of hexosaminidases.,"Lysosomal Storage Disorders:Potent inhibitor of β-N-acetylglucosaminidases, enzymes critical in glycosphingolipid metabolism. Targets fucosidosis and Sandhoff disease by reducing pathogenic substrate accumulation"
2008,https://doi.org/10.1021/cr078215f,synthetic,heparan sulfate,Alzhemed (tramiprosate; 3-amino-1-propanesulfonic acid),"small synthetic GAG-based mimetic currently in phase III clinical trials, promising from phase II clinical trials in patients with mild-to-moderate Alzheimer’s disease, suggesting the potential of such approaches for the treatment of this disorder.","Alzheimer’s Disease (AD):Tramiprosate binds to amyloid-beta (Aβ42), inhibiting oligomerization and plaque formation. It stabilizes Aβ monomers, providing neuroprotection and reducing cognitive decline, particularly in ApoE4 homozygous patients"
2008,https://doi.org/10.1021/ol8006259,Aldohexose,galactose,mannose,galactose-mimicking substrate,"MPI-CDG (Congenital Disorder of Glycosylation):
Corrects glycosylation defects, stabilizes immune function, and reduces infections"
2008,https://doi.org/10.1016/j.carres.2008.04.015,Cluster Glycoside Mimetic,Mannose,Unprotected clustermannoside,Scaffold for trivalent glycocluster,"Urinary Tract Infections (UTIs):Inhibits FimH-mediated bacterial adhesion in E. coli, preventing bladder colonization"
2008,https://doi.org/10.1016/j.carres.2008.04.015,Scaffold for Mimetics,NA ,Tris(hydroxymethyl)aminomethane,Scaffold for trivalent glycocluster,"Metabolic Acidosis:Buffers acidemia in critical care settings (e.g., sepsis, cardiac arrest, hypercapnic respiratory failure) without causing hypernatremia"
2008,https://doi.org/10.1111/j.1747-0285.2008.00741.x,GAG Mimetics,heparan sulfate (HS),synthetic pentasaccharide Arixtra (Fondaparinux or SR90107 ⁄ Org31540),Anticoagulant,"Sepsis-Induced Coagulopathy:Inhibits factor Xa, reducing coagulation activation and improving survival in E. coli sepsis models"
2008,https://doi.org/10.1111/j.1747-0285.2008.00741.x,GAG Mimetics,heparan sulfate (HS),Idraparinux (SANORG 34006),"phase III clinical trials for the treatment of venous thromboembolism, anticogulant ",Venous Thromboembolism (VTE):idraparinux is a synthetic pentasaccharide anticoagulant that inhibits Factor Xa. It was investigated for treating deep vein thrombosis (DVT) and pulmonary embolism (PE). 
2008,https://doi.org/10.1111/j.1747-0285.2008.00741.x,GAG Mimetics,heparan sulfate (HS),synthetic hexadecasaccharide SR123781,Anticoagulant,Potent antithrombotic agent in venous and arterial thrombosis models
2008,https://doi.org/10.1111/j.1747-0285.2008.00741.x,GAG Mimetics,heparan sulfate (HS),PI-88,"progressed to clinical trials to treat inflammatory diseases, thrombosis, virus infections and cancer; Anticancer, Anti-inflammatory",Hepatocellular carcinoma (Phase III trials)
2008,https://doi.org/10.1111/j.1747-0285.2008.00741.x,GAG Mimetics,NA ,Poly-acrylic Acid (PAA),Anticoagulant,"Dry Eye Syndrome:Superior to polyvinyl alcohol in reducing symptoms (gritty sensation, photophobia) and improving tear film stability"
2008,https://doi.org/10.1111/j.1747-0285.2008.00741.x,GAG Mimetics,sulfated glycosaminoglycans (GAGs),Epicatechin Sulfate (ECS),Anticoagulant,"Cardiovascular Diseases:Reverses endothelial cell aging, improves nitric oxide production, and enhances vascular relaxation"
2008,https://doi.org/10.1016/j.tetlet.2008.05.040,Cyclitol-Based Mimetics,a-L-rhamnopyranose,"3,5-di-O-benzyl-D-pinitol","Mimics α-L-rhamnopyranose unit in bioactive saccharides, interacts with dendritic cells, potential use in stable mimic of capsular polysaccharide in Streptococcus pneumoniae",Inhibits breast and prostate cancer growth via NF-κB/MMP-9 and FAK/c-Src pathways
2008,https://doi.org/10.1016/j.carres.2008.09.002,Glycolipid Mimetics,GM3 (ganglioside),"2-aminododecyl (5-acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-D-glyceroa-D-galacto-2-nonulopyranosyl)onate-(2?3)-2,4,6-tri-O-acetyl-bD-galactopyranosyl-(1?4)-2,3,6-tri-O-acetyl-b-D-glucopyranoside","Mimics the lyso-GM3 structure, binds to epidermal growth factor receptor (EGFR)","Influenza:These glycosides mimic sialic acid and inhibit viral neuraminidases, blocking viral release and reducing infection severity"
2008,https://doi.org/10.1016/j.bmc.2007.11.036,Iminosugar,Glucose,Deoxynojirimycin (DNJ),Inhibitor of α-glucosidase,"Type II Diabetes:DNJ inhibits α-glucosidase, reducing postprandial hyperglycemia"
2008,https://doi.org/10.1016/j.bmc.2007.11.036,Iminosugar,Glucose,N-butyl-1-deoxynojirimycin (Zavesta),Inhibitor of ceramide-specific glucosyltransferase,"Gaucher’s Disease:Zavesca inhibits glucosylceramide synthase, alleviating lysosomal storage pathology in non-neuronopathic Gaucher’s disease"
2008,https://doi.org/10.1016/j.bmc.2007.11.036,Iminosugar,Glucose,N-hydroxyethyl-DNJ (miglitol),Treatment for type II diabetes,"Type II Diabetes:Similar to DNJ, miglitol inhibits intestinal α-glucosidase, improving glycemic control"
2008,https://doi.org/10.1016/j.bmc.2007.11.036,Iminosugar,α-D-mannose,Swainsonine,Glycosidase inhibitor,"Cancer Therapy:Swainsonine inhibits α-mannosidase II, disrupting N-glycan processing and suppressing tumor metastasis"
2008,https://doi.org/10.1016/j.bmc.2007.11.036,Iminosugar,L-fucose,Fuconojirimycin,Inhibitor of fucosyltransferase,"Lysosomal Storage Disorders:L-fuco-nojirimycin is a potent inhibitor of α-L-fucosidase, potentially useful for treating fucosidosis and other lysosomal storage diseases"
2009,https://www.nature.com/articles/nrd2852.pdf,glycomimetic,sialic acid,Zanamivir (Relenza),"Zanamivir functions as an inhibitor of viral neuraminidases, which is used for the prevention of influenza virus infections",Influenza: Neuraminidase inhibitors preventing viral release
2009,https://www.nature.com/articles/nrd2852.pdf,glycomimetic,sialic acid,Oseltamivir phosphate (Tamiflu),"Oseltamivir phosphate (Tamiflu) functions as an inhibitor of viral neuraminidases, which is used for the treatment of influenza virus infections",Influenza: Neuraminidase inhibitors preventing viral release
2009,https://www.nature.com/articles/nrd2852.pdf,glycomimetic,α-glucosidase inhibitor,Voglibose (Glustat),Voglibose (Glustat) functions as an α-glucosidase inhibitor used for the treatment of diabetes,type 2 diabetes mellitus. It is an alpha-glucosidase inhibitor that helps control postprandial (after-meal) blood glucose levels by delaying the digestion and absorption of complex carbohydrates in the small intestine
2009,https://doi.org/10.1002/ejoc.200900945,glycosides,pyranose,di-O-isopropylidene-glucose,"Di-O-isopropylidene-glucose is used as a starting material for the synthesis of glycoaminoxy acids, which are a novel type of sugar building blocks and oligosaccharide mimetics. It is chosen for its ready availability and low cost, and it allows for the introduction of functional groups necessary for further chemical transformations","Protected sugars used to develop glycan-based drugs (e.g., antiviral agents)"
2009,https://doi.org/10.1002/ejoc.200900945,imino sugar derivative,D-Ribose,D-ribofuranoid glycoaminoxy acid,"D-ribofuranoid glycoaminoxy acid functions as a novel sugar building block and oligosaccharide mimetic. It is used in the synthesis of homo-oligomers, which are oligosaccharide mimetics","Antiviral Drug Design:scaffolds for neuraminidase inhibitors (e.g., zanamivir) and nucleoside analogs. "
2009,https://doi.org/10.1002/ejoc.200900945,imino sugar derivative,pyranose,Pyranoid glycoaminoxy acids,Pyranoid glycoaminoxy acids function as a new class of sugar building blocks. They are used for the synthesis of oxyamide-linked disaccharides and glycosyl amino acid mimetics due to the presence of both aminoxy and carboxylic acid functional groups on the sugar ring,"Metabolic Disorders:Act as synthetic analogs of glycosphingolipids to address lysosomal storage diseases (e.g., Gaucher, Fabry) by stabilizing defective enzymes"
2009,https://doi.org/10.1002/ejoc.200900945,glycoside, oligosaccharide,di-O-isopropylidene-D-glucose,"Di-O-isopropylidene-D-glucose serves as a versatile synthetic intermediate in carbohydrate chemistry, primarily functioning as a protected glucose derivative with strategic hydroxyl group masking.","Antibiotic Production:Key intermediate in synthesizing cephalosporins and penicillins, used to treat bacterial infections"
2009,https://doi.org/10.1002/ejoc.200900945,glycoside,oligosaccharide,D-ribofuranoid glycoaminoxy acid,D-Ribofuranoid glycoaminoxy acid is a synthetic derivative of β-D-ribofuranose (the five-membered ring form of ribose) modified with an aminoxy group (–ONH₂) and a carboxylic acid (–COOH),Diabetic Nephropathy: Heparin analogs reduce advanced glycation end products (AGEs) and glomerular permeability
2009,https://doi.org/10.1002/chem.200900996,imino sugar derivative,amino sugar,"3,6-dihydro-2H-1,2-oxazines","Carbohydrate mimetics: 3,6-Dihydro-2H-1,2-oxazines mimic carbohydrates, interacting with carbohydrate-binding proteins.","Inhibit platelet aggregation, useful in cardiovascular diseases (e.g., thrombosis)"
2009,https://doi.org/10.1039/B914356D,Miscellaneous,mannose,"1,2-oxazines syn-8 ( Bicyclic ketones 15)","Bicyclic ketone 15 serves as an ideal starting point for the preparation of suitable substrates for the copper-catalyzed 1,3-dipolar cycloaddition of azides with alkynes, which is a key step in the synthesis of oligosaccharide mimetics","Cancer: Serve as intermediates for polyoxygenated oxepanes, which target cancer cell proliferation"
2009,https://doi.org/10.1039/B914356D,Miscellaneous,glucosamine,"1,2-oxazines anti syn-8 ( Bicyclic ketones 17)","The 1,2-oxazines syn-8, when exposed to Lewis acids, can be transformed into either bicyclic ketones 15 or tricyclic compounds 16, depending on the nature of the 4-alkoxy group [1]. Additionally, the 1,2-oxazines syn-8 and anti-8 can undergo Lewis acid-promoted rearrangements leading to bi- and tricyclic products","Cancer: Serve as intermediates for polyoxygenated oxepanes, which target cancer cell proliferation"
2010,https://doi.org/10.4155/fmc.10.8,glycosidases,O-glycoside,C-glycosides,"C-glycosides serve as stable mimics of glycosides by replacing the anomeric oxygen with a carbon atom, which suppresses the reactivity of the anomeric center. This stability makes them useful in medicinal chemistry, as they are unable to undergo the metabolism of the parent sugar, allowing them to participate in biological processes of pharmacological relevance without being metabolized",Diabetes: Voglibose inhibits α-glucosidase
2010,https://doi.org/10.1517/17460441.2010.497811,iminosugar ,glucose,miglitol (N-(2-hydroxyethyl)-nojirimycin),"able to prevent digestion of carbohydrates by a-glucosidase inhibition , anti-diabetic and antiobesity compound",Type 2 Diabetes: Reduces postprandial glucose spikes as an α-glucosidase inhibitor
2010,https://doi.org/10.1517/17460441.2010.497811,iminosugar ,glucose,N-butyl-deoxynojirimycin,"acting as an inhibitor of glucosylceramide synthase and a-glucosidase, administered for the treatment of type 1 Gaucher disease",Gaucher/Niemann-Pick Diseases: Reduces glycolipid accumulation in lysosomal storage disorders
2010,https://doi.org/10.1517/17460441.2010.497811,iminosugar,mannose,swainsonine,anticancer drug with the potential of treating glioma [120] and gastric carcinoma,Lung cancer: Inhibits A549 cell growth in vitro and reduces xenograft tumor volume in vivo
2010,https://doi.org/10.1517/17460441.2010.497811,iminosugar,Oligosaccharides,acarbose," It is an inhibitor of α-glucosidases and α-amylases, enzymes involved in carbohydrate metabolism.",Type 2 Diabetes: Lowers HbA1c levels by delaying carbohydrate digestion
2010,https://doi.org/10.1517/17460441.2010.497811,iminosugar,- α-D-Glucopyranose,Validamycin A,a non-systemic antibiotic with fungicide action produced from the fermentation of Streptomyces hygroscopicus subspecies limoneus,Antifungal agent against rice sheath blight (Rhizoctonia solani)
2010,https://doi.org/10.1517/17460441.2010.497811,Mixed-Type Oligosaccharides,glycosaminoglycan,idraparinux," Idraparinux is a synthetic analog of the antithrombin-binding region of heparin, which is a critical site for heparin's anticoagulant activity.",Venous Thromboembolism (VTE):idraparinux is a synthetic pentasaccharide anticoagulant that inhibits Factor Xa. It was investigated for treating deep vein thrombosis (DVT) and pulmonary embolism (PE). 
2010,https://doi.org/10.1517/17460441.2010.497811,Mixed-Type Oligosaccharides,glycosaminoglycan,arixtria,"Arixtra is a synthetic analog of the antithrombin-binding region of heparin, which is a critical site for heparin's anticoagulant activity.","Thromboembolic Disorders:Approved for preventing DVT post-surgery (hip/knee replacement) and treating acute DVT/PE. It blocks Factor Xa, reducing clot formation. Also used for unstable angina and myocardial infarction"
2010,https://doi.org/10.1016/j.bmc.2010.08.027,miscellanous,"glucose,mannose",sialic acid,"Carbohydrate mimetics are designed to mimic the structure and function of carbohydrates, often to improve pharmacokinetic properties and binding affinities. In the context of the document, a non-carbohydrate mimic was synthesized to act as an antagonist of the myelin-associated glycoprotein (MAG), which is involved in blocking the regeneration of neurite injuries. The goal was to address pharmacokinetic issues such as metabolic stability while maintaining or improving binding affinity to the target protein",Influenza (via neuraminidase inhibitors like oseltamivir and zanamivir)
2010,https://doi.org/10.1021/jo101219w,miscellanous,pyranose,"2,3-dihydro-4-pyridinones","2,3-dihydro-4-pyridinones an important class of compounds in medicinal chemistry and drug discovery","Inhibit kinases (e.g., EGFR, STAT3) in lung, gastric, and breast cancers."
2010,https://doi.org/10.1016/B978-0-12-374546-0.00047-X,Thioglycosides,sialic acid,Thiosialosides,Thiosialosides are used as probes for sialic acid recognizing proteins and have been evaluated for their ability to inhibit influenza virus neuraminidase,"Influenza:Bifunctional thiosialosides inhibit viral neuraminidase (NA), preventing viral release. They show nanomolar efficacy against H1N1 and H3N2 strains"
2010,https://doi.org/10.1016/B978-0-12-374546-0.00047-X,Thioglycosides,sialic acid,Thiogangliosides,Thiogangliosides have been evaluated for their ability to inhibit influenza virus neuraminidase,"Influenza:Bifunctional thiosialosides inhibit viral neuraminidase (NA), preventing viral release. They show nanomolar efficacy against H1N1 and H3N2 strains"
2010,https://doi.org/10.1016/B978-0-12-374546-0.00047-X,Thioglycosides,sialic acid,Polymeric thiosialosides,Polymeric thiosialosides have been evaluated for their ability to inhibit influenza virus neuraminidase,"Influenza:Bifunctional thiosialosides inhibit viral neuraminidase (NA), preventing viral release. They show nanomolar efficacy against H1N1 and H3N2 strains"
2010,https://doi.org/10.1016/B978-0-12-374546-0.00047-X,Thioglycosides,galactofuranosides,Galactofuranosyl alkyl thioglycosides,"Galactofuranosyl alkyl thioglycosides function as inhibitors of mycobacterial growth, specifically targeting Mycobacterium smegmatis. They are of interest as potential tuberculosis therapeutics due to their ability to mimic the structural characteristics of galactofuranosides, which are essential components of the mycobacterial cell wall ","Bacterial Infections:Target pathogens with galactofuranose-containing glycans (e.g., Mycobacterium tuberculosis) by inhibiting cell wall synthesis"
2010,https://doi.org/10.1016/B978-0-12-374546-0.00047-X,Iminosugars,α-glycosides,1-deoxynojirimycin ,"1-Deoxynojirimycin functions as a glycosidase inhibitor. It derives its ability to inhibit glycohydrolases from the nitrogen in the ring, which can support a positive charge, enabling it to mimic the transition state characteristic of the hydrolysis of α-glycosides","Type 2 Diabetes:DNJ and miglitol inhibit intestinal α-glucosidase, reducing postprandial hyperglycemia"
2010,https://doi.org/10.1016/B978-0-12-374546-0.00047-X,Iminosugars,mannose,N-butyldeoxygalactonojirimycin,N-butyldeoxygalactonojirimycin is mentioned as having potential for the treatment of β-galactosidosis,"Type 2 Diabetes:DNJ and miglitol inhibit intestinal α-glucosidase, reducing postprandial hyperglycemia"
2010,https://doi.org/10.1016/B978-0-12-374546-0.00047-X,Iminosugars,mannose,1-deoxymannojirimycin,1-Deoxymannojirimycin functions as a glycosidase inhibitor,"Type 2 Diabetes:DNJ and miglitol inhibit intestinal α-glucosidase, reducing postprandial hyperglycemia"
2010,https://doi.org/10.1016/B978-0-12-374546-0.00047-X,Iminosugars,galactose, 1-deoxygalactostatin ,1-deoxygalactostatin as one of the glycosidase inhibitors derived from a single molecule,"Diabetic Complications: Inhibits advanced glycation end-product (AGE) formation by targeting pathways involving 3-deoxyglucosone (3-DG), a precursor to AGEs linked to diabetic neuropathy, retinopathy, and nephropathy"
2010,https://doi.org/10.1016/B978-0-12-374546-0.00047-X,Iminosugars,mannose,Swainsonine,Swainsonine functions as a glycosidase inhibitor,"Cancer:Inhibits α-mannosidase II, disrupting N-glycan processing and suppressing tumor metastasis in preclinical models"
2010,https://doi.org/10.1016/B978-0-12-374546-0.00047-X,carbasugars,glucose,Cyclitol epoxide ,Cyclitol epoxide functions as a carbasugar analogue of D-glucose and is one of the most potent and specific competitive inhibitors of almond and Molt-4 lysate β-glucosidases ,"Antiviral/Metabolic Disorders:Acts as a glycosidase inhibitor, potentially targeting viral entry or carbohydrate metabolism pathways (similar to DNJ)"
2010,https://doi.org/10.1016/B978-0-12-374546-0.00047-X,miscellanous,sialosyl cation,Relenza,Relenza functions as an anti-influenza drug. It was designed by detailed analysis of the catalytic site within influenza virus neuraminidase and is known for its inhibitory activity against this enzyme,Influenza A/B:Neuraminidase inhibitor used for treatment (within 48 hours of symptom onset) and prophylaxis. Reduces symptom duration and transmission risk
2010,https://doi.org/10.4155/fmc.10.8,inhibitor,glucosidase,zanamivir,Acts as an anti-influenza drug,Influenza A/B: Neuraminidase inhibitors that reduce viral replication. Effective if administered within 48 hours of symptom onse
2010,https://doi.org/10.4155/fmc.10.8,inhibitor,glucosidase,oseltamivir,Acts as an anti-influenza drug,Influenza A/B: Neuraminidase inhibitors that reduce viral replication. Effective if administered within 48 hours of symptom onse
2010,https://doi.org/10.4155/fmc.10.8,inhibitor,glucosidase,miglitol,the antidiabetic and antiobesity compound,"Type 2 Diabetes: Slows carbohydrate digestion, improving glycemic control"
2010,https://doi.org/10.4155/fmc.10.8,inhibitor,iminosugar,nojirimycin,prevents digestion of carbohydrate and used as a treatment for type 2 diabetes,"Inflammation: Suppresses NF-κB and MAPK pathways, reducing NO and cytokine production"
2010,https://doi.org/10.4155/fmc.10.8,inhibitor,iminosugar,N-butyl-deoxynojirimycin,used for the treatment of type 1 Gaucher disease,"Type 2 Diabetes:DNJ and miglitol inhibit intestinal α-glucosidase, reducing postprandial hyperglycemia"
2010,https://doi.org/10.4155/fmc.10.8,inhibitor,glucosidase,Swainsonine,used as an anticancer drug with potential for treating glicoma and stomach cancer,"Cancer:Inhibits α-mannosidase II, disrupting N-glycan processing and suppressing tumor metastasis in preclinical models"
2011,https://doi.org/10.1039/C1OB05583F,Mixed-Type Oligosaccharides,pyranose,monocyclic aminopyrans,"Monocyclic aminopyrans function as carbohydrate mimetics used to enhance the binding affinities of gold colloids by converting their hydroxyl groups into sulfate functionalities. They are used to study the binding properties of sulfated epitopes with different configurations and substitution patterns, particularly in relation to their interaction with selectins",Antimicrobial/Anticancer: Structural analogs of imidazoles targeting kinases or microbial enzymes
2011,https://doi.org/10.1039/C1OB05583F,Mixed-Type Oligosaccharides,N-acetylglucosamine (NAG),aminofurans,"Aminofurans function as carbohydrate mimetics used to study the binding properties of sulfated epitopes. They are involved in enhancing the binding affinities of gold colloids by converting their hydroxyl groups into sulfate functionalities. Specifically, sulfated aminofurans have been shown to exhibit binding to P-selectin and L-selectin, with some selectivity observed based on their structural features",Alzheimer's disease
2011,https://doi.org/10.1039/C1OB05583F,Mixed-Type Oligosaccharides,d-fructose,acyclic aminopolyols,"Acyclic aminopolyols function as carbohydrate mimetics used to enhance selectin binding properties. They are attached to gold colloids and sulfated to improve ligand-receptor interactions. These sulfated colloids exhibit strong selectin binding properties and no signs of cytotoxicity, serving as a valuable example of improved ligand-receptor interactions when presented multivalently","Diabetes, Viral Infections, Cancer: Synthesized via biocatalytic amination of sugars, these compounds act as carbohydrate mimetics for diabetes management, antiviral therapies, and antitumor agents"
2011,https://doi.org/10.1073/pnas.1105057108,peptide,Lewis A carbohydrate,"I-peptide, which is a 7-mer peptide","The function of I-peptide, which is a 7-mer peptide, is to inhibit sialyl Lewis X-dependent colonization by binding to a receptor distinct from E- or P-selectins. It was found to bind to a 15 kDa fragment of annexin 1 (Anxa1), which is a highly specific marker of the tumor vasculature surface","Cancer: Targets annexin 1 (Anxa1) on tumor vasculature for drug delivery. Conjugated to SN-38 (chemotherapy drug), it suppresses colon cancer (HCT116) growth in mice"
2011,https://doi.org/10.2174/138955711793564060,Iminosugars,glucose,1-deoxynojirimycin (DNJ),1-deoxynojirimycin (DNJ) functions as a glycosidase inhibitor. It is a stable and powerful inhibitor of both α- and β-glucosidases,"Diabetes: Inhibits α-glucosidase, reducing postprandial hyperglycemia"
2011,https://doi.org/10.2174/138955711793564060,Iminosugars,glucose,nojirimycin,Nojirimycin functions as a glycosidase inhibitor. It has shown inhibitory activity towards both α- and β-glucosidases,"Bacterial Infections: Inhibits Xanthomonas oryzae, Shigella flexneri, and Mycobacterium smegmatis"
2011,https://doi.org/10.2174/138955711793564060,Iminosugars,glucose,α-Homonojirimycin,α-Homonojirimycin functions as a potent glycosidase inhibitor ,"Antiviral Research: Inhibits viral replication (e.g., HIV) and modulates glycosylation pathways"
2011,https://sci-hub.se/10.1055/s-0030-1260139,imino sugar derivative,oligosaccharide,"2,6-functionalized pyranoid glycoaminoxy acid","The 2,6-functionalized pyranoid glycoaminoxy acid serves as a building block for the construction of novel 2,6-linked oligosaccharide mimetics. It is used for chemical ligations with various amines, carboxylic acids, or aldehydes through amide, oxime, or oxyamine bonds, respectively. This makes it a useful tool for the synthesis of oligosaccharide mimetics with potentially diverse practical application",Cancer: Used to synthesize oligosaccharide mimetics that inhibit tumor growth and metastasis
2011, https://doi.org/10.1134/S1068162011060100,Mixed-Type Oligosaccharides, heparinoids,Sulfated Phosphomannan PI88,"Sulfated phosphomannan PI88 functions as a heparanase inhibitor and an angiogenesis inhibitor. It blocks the action of heparanase, which is involved in cancer cell metastasis, and interacts with growth factors (FGF-1, FGF-2, VEGF) and their receptors (FGFR) to inhibit angiogenesis","Hepatocellular Carcinoma (HCC): Inhibits heparanase, reducing tumor growth and metastasis in clinical trials"
2011, https://doi.org/10.1134/S1068162011060100,Mixed-Type Oligosaccharides, heparinoids,dextran sulfate (DS),"Dextran sulfate functions as an inhibitor of viral adhesion, specifically inhibiting the primary adsorption of viruses like HIV on the cell membrane, thus preventing the initial stage of infection. However, its practical use as a drug is limited due to low bioaccessibility and challenges in standardization and structural characterization","Type 1 Diabetes (T1D): Preserves β-cell mass, reverses hyperglycemia in preclinical models"
2011, https://doi.org/10.1134/S1068162011060100,Mixed-Type Oligosaccharides, heparinoids,pentosan sulfate (HOE/BAY946),"Pentosan sulfate (HOE/BAY946) functions as an inhibitor of viral adhesion, similar to dextran sulfate. It can inhibit the primary adsorption of viruses like HIV on the cell membrane, thus preventing the initial stage of infection. However, like other sulfated polysaccharides, its practical use as a drug is limited due to low bioaccessibility and challenges in standardization and structural characterization.",Osteoarthritis: Reduces cartilage degradation in preclinical studies
2011, https://doi.org/10.1134/S1068162011060100,Mixed-Type Oligosaccharides, heparinoids,sulfated hexasaccharide,"Sulfated hexasaccharides play diverse biological roles due to their structural and sulfation patterns. Neurodevelopment: Promote cerebellar Purkinje cell growth and neurite outgrowth by interacting with neurotrophic factors like pleiotrophin.Growth Factor Modulation: Mimic heparan sulfate to regulate fibroblast growth factor 2 (FGF-2) activity, influencing cell proliferation and disease pathways.Immune Regulation: Inhibit selectins (L-, E-, and P-selectins) to modulate inflammation, lymphocyte homing, and tumor metastasis.","Cancer Metastasis: Dual inhibition of heparanase and selectins, blocking tumor cell spread"
2011, https://doi.org/10.1134/S1068162011060100,Miscellanous, heparinoids,Sulfated bisamide,"Sulfated bisamide of aldonic acid (186) is ascribed to this type of compound (Scheme 29). At first com pound (186) was supposed to be used as an antithrom botic drug [55, 56] and was synthesized in four stages from lactobionic acid (185), which was primarily transformed into bisamide with 1,3propanediamine using the cationexchange resin LewatitS100, and then was subjected to exhaustive sulfation with the complex Py ⋅ SO3 to form hexadecasulfate (186). This compound manifested relatively high anticoagulant activity, presumably inhibiting thrombin in a complex with heparin cofactor II (HCII).",Antimicrobial: Mimic glycopeptides to target bacterial cell walls
2011,https://doi.org/10.1016/j.tetlet.2011.05.063,iminosugar,glucose,2-deoxynojirimycin,"2-Deoxynojirimycin (2-DNJ) is a mimic of glucose, specifically targeting enzymes involved in carbohydrate metabolism. It is a polyhydroxylated piperidine that structurally resembles the pyranose form of glucose, enabling it to act as a potent inhibitor of glycosidases, particularly α-glucosidase and other carbohydrate-processing enzymes.","Type 2 Diabetes: Miglitol (a DNJ derivative) inhibits intestinal α-glucosidases, reducing postprandial hyperglycemia"
2011,https://doi.org/10.1016/j.tetlet.2011.05.063,iminosugar,D-glucose,Miglustat ,"Miglustat, also known as N-butyl-deoxynojirimycin (NB-DNJ), is used for the treatment of progressive neurological manifestations in adults and pediatric patients with Niemann–Pick type C disease. It is commercialized by Actelion and is noted for its enhanced lipophilicity due to the alkyl chain on the endocyclic nitrogen, which tends to exhibit better in vivo biological activities compared to the parent iminosugars",Gaucher Disease: Reduces glucosylceramide accumulation via substrate reduction therapy
2011,https://doi.org/10.1016/j.tetlet.2011.05.063,iminosugar,D-glucose,Miglitol ,"Miglitol, also known as N-hydroxyethyldeoxynojirimycin, is developed by Bayer and is used to treat type II diabetes. It functions through its strong inhibiting effect against alpha-glucosidase in the human body, which helps block the digestion of dietary carbohydrates into glucose","Type 2 Diabetes: Slows carbohydrate digestion, improving glycemic control"
2012,https://dx.doi.org/10.2174/138955712803832690,Glycomimetic,"1,2-mannobioside","Pseudo-1,2-mannobioside+F2:F155","Pseudo-1,2-mannobioside  acts as a mimic of  a reducing end mannose residue and features a spacer-arm terminated with azido or amino functionality, useful to generate multivalent DC-SIGN ligands.","Mimics mannose to interact with DC-SIGN receptors, aiding in pathogen adhesion studies."
2012,https://dx.doi.org/10.2174/138955712803832690,Glycomimetic,"linear Man (1,2)Man (1,6)Man trisaccharide","pseudo-trisaccharide, 2","This compound inhibits DC-SIGN binding to mannosylated BSA (Bovine serum albumin) with an IC50 of 130 M (by surface-plasmon resonance, SPR).","Potential anti-infective agent by blocking DC-SIGN receptor interactions, which could inhibit pathogen entry and infection processes"
2012,https://doi.org/10.1016/j.bmcl.2012.04.014,Glycomemitics,Heparan Sulphate,PI-88,"a highly sulfonated oligosaccharide that mimics heparan sulfate and has potent anti-angiogenic activity, currently in clinical trials","Inhibits heparanase activity and angiogenesis, showing potential as an anti-cancer and anti-metastatic agent."
2012,https://doi.org/10.1016/j.bmcl.2012.04.014,Glycomemitics,Heparan Sulphate,Small molecule fluoro-xylosides,"small molecules that mimic heparan sulfate and potently reduce tumor-associated angiogenesis by inhibiting HS biosynthesis in vitro, requiring cellular entry to be effective","Disrupts HS biosynthesis, leading to reduced tumor angiogenesis and potential anti-cancer applications."
2012,https://doi.org/10.1016/j.bmcl.2012.04.014,Glycomemitics,Heparan Sulphate,Polysulfonated small molecules,"these mimic heparin/heparan sulfate and act as inhibitors of angiogenesis, identified as promising in vitro tube formation assay inhibitors and can be easily synthesized","Prevents angiogenesis by inhibiting heparan sulfate interactions, making them potential therapeutic agents for cancer treatment."
2012,https://doi.org/10.2174/138955712803832672,Aminoglycoside antibiotic,Streptamine-based pseudo-oligosaccharide,Streptomycin,Binds to the 30S subunit of ribosomal RNA (rRNA) to inhibit protein synthesis.,Effective against Mycobacterium tuberculosis
2012,https://doi.org/10.2174/138955712803832672,Aminoglycoside antibiotic,2-Deoxystreptamine (2-DOS) based pseudo-oligosaccharide,Neomycins,Binds to rRNA to prevent normal translation of proteins.,Broad-spectrum antibiotic activity
2012,https://doi.org/10.2174/138955712803832672,Aminoglycoside antibiotic,2-Deoxystreptamine (2-DOS) based pseudo-oligosaccharide,Paramomycins,Binds to rRNA to inhibit protein synthesis.,Broad-spectrum antibiotic activity
2012,https://doi.org/10.2174/138955712803832672,Aminoglycoside antibiotic,2-Deoxystreptamine (2-DOS) based pseudo-oligosaccharide,Kanamycins,Binds to rRNA to inhibit protein synthesis.,Broad-spectrum antibiotic activity
2012,https://doi.org/10.2174/138955712803832672,Aminoglycoside antibiotic,2-Deoxystreptamine (2-DOS) based pseudo-oligosaccharide,Gentamicins,Binds to rRNA to inhibit protein synthesis.,Broad-spectrum antibiotic activity
2012,https://doi.org/10.2174/138955712803832672,Aminoglycoside antibiotic,2-Deoxystreptamine (2-DOS) based pseudo-oligosaccharide,Tobramycins,Binds to rRNA to inhibit protein synthesis.,Broad-spectrum antibiotic activity
2012,https://doi.org/10.2174/138955712803832672,Semi-synthetic aminoglycoside antibiotic,2-Deoxystreptamine (2-DOS) based pseudo-oligosaccharide,Amikamycins,Binds to rRNA to inhibit protein synthesis.,"Effective against resistant bacteria, particularly Gram-negative pathogens"
2012,https://doi.org/10.2174/138955712803832672,Semi-synthetic aminoglycoside antibiotic,2-Deoxystreptamine (2-DOS) based pseudo-oligosaccharide,Dibekacins,Binds to rRNA to inhibit protein synthesis.,"Active against aminoglycoside-resistant strains, used for treating severe infections"
2012,https://doi.org/10.2174/138955712803832672,Semi-synthetic aminoglycoside antibiotic,2-Deoxystreptamine (2-DOS) based pseudo-oligosaccharide,Sisomicins,Binds to rRNA to inhibit protein synthesis.,"Broad-spectrum activity, effective against Pseudomonas aeruginosa and other resistant pathogens"
2012,https://doi.org/10.2174/138955712803832672,Semi-synthetic aminoglycoside antibiotic,2-Deoxystreptamine (2-DOS) based pseudo-oligosaccharide,Netilmicins,Binds to rRNA to inhibit protein synthesis.,"Active against aminoglycoside-resistant bacteria, lower ototoxicity compared to other aminoglycosides"
2012,https://doi.org/10.1155/2012/740982,GD1α-mimetic peptide,GD1α (a ganglioside),GD1 α-mimetic peptides,"These peptides functionally mimic GD1α, which is an adhesion molecule involved in tumor metastasis.",GD1α-replica peptides suppress tumor metastasis.
2012,https://doi.org/10.1155/2012/740982,Oligosaccharide-mimetic peptide,Sialyl-Lewis X (sLeX),sLe X-mimetic peptides,"These peptides inhibit binding to E-selectin, which is involved in cell adhesion processes.","inhibit the binding of E-selectin, thereby reducing neutrophil rolling and adhesion to endothelial cells during inflammatory responses."
2012,https://doi.org/10.1155/2012/740982,Peptide mimetic,α-Gal (Galα1-3Gal),Peptide mimetics of xenoreactive α-Gal antigenic epitope,"These mimetics are designed to mimic the α-Gal epitope, which is known to elicit strong immune responses in humans, particularly in the context of xenotransplantation.","The peptide mimetics can potentially inhibit the binding of anti-α-Gal antibodies, thereby reducing the risk of hyperacute rejection in xenotransplantation scenarios."
2012,https://doi.org/10.1593/neo.111544,Carbohydrate-based galectin inhibitor,Galactoside-containing polysaccharide,Modified Citrus Pectin (MCP),"Inhibits galectin-3, blocking its antiapoptotic function and tumor cell clonogenic survival","Shown to inhibit experimental metastasis in various animal models, including melanoma and prostate carcinoma"
2012,https://doi.org/10.1593/neo.111544,Synthetic β-galactoside disaccharide/amino acid conjugate,Cancer-associated Thomsen-Friedenreich antigen (TF-Ag),Glycoamine Lactulose-L-leucine (Lac-L-Leu),"Binds and inhibits galectin-3, mimicking TF-Ag",Impedes metastasis-associated tumor cell adhesive interactions and inhibits the formation of early metastatic deposits in lungs and bones
2012,https://doi.org/10.1371/journal.pone.0035457,Carbohydrate mimetic peptide,GD2 ganglioside,Peptides mimicking GD2 ganglioside,"These peptides are designed to mimic the structure of GD2 ganglioside, which is a tumor-associated antigen.","They elicit immune responses, including cellular and humoral immunity, and can potentially be used in cancer immunotherapy"
2012,https://doi.org/10.1371/journal.pone.0035457,Carbohydrate mimetic peptide,GD3 ganglioside,Peptides mimicking GD3 ganglioside,"Similar to GD2 mimics, these peptides replicate the structure of GD3 ganglioside, facilitating recognition by specific antibodies.","They can induce anti-ganglioside immune responses, contributing to the development of therapeutic strategies against cancers expressing GD3"
2012,https://doi.org/10.1016/j.carres.2012.05.024,Carbohydrate Mimetic,Pentasaccharide,Octapeptide 2,Binds to the SYA/J6 antibody with moderate affinity,"Potential use in developing vaccines or therapeutics targeting diseases where pentasaccharide recognition plays a role, such as certain bacterial infections or autoimmune disorders"
2012,https://doi.org/10.1016/j.carres.2012.05.024,Glycopeptide mimetic,Structural elements from the pentasaccharide and the octapeptide,a-Glycopeptide 3,"Designed to mimic natural antigens for vaccine development. Interacts with the antibody primarily on the periphery of the combining site, with some residues maintaining interactions similar to those in the pentasaccharide","Potential use in vaccine development against pathogens that express similar carbohydrate structures, possibly including certain bacterial strains or parasites. May also have applications in autoimmune diseases where antibodies against specific carbohydrate structures are involved."
2012,https://doi.org/10.1016/j.carres.2012.05.024,Glycopeptide mimetic,Structural elements from the pentasaccharide and the octapeptide,b-Glycopeptide 4,Designed to mimic natural antigens for vaccine development,Potential use in vaccine development against pathogens expressing similar carbohydrate structures. May also have applications in treating autoimmune diseases where antibodies against specific carbohydrate structures are involved.
2012,DOI: 10.2174/138955712803832753,Synthetic carbohydrate mimetic,GDP-fucose,GDP-hexanolamine,Inhibitors of fucosyltransferases,"Potential treatment for cancer and inflammatory diseases by inhibiting fucosylation processes involved in cell-cell recognition, cell adhesion, and signaling pathways"
2012,DOI: 10.2174/138955712803832753,Synthetic carbohydrate mimetic,Trisaccharide	,Azatrisaccharide containing a piperidine ring,Inhibitor of glycosyltransferases,Potential treatment for cancer and inflammatory diseases by inhibiting aberrant glycosylation processes
2012,DOI: 10.2174/138955712803832753,Synthetic carbohydrate mimetic,N-Ac-lactosamine,N-Ac-lactosamine mimetics,Inhibitor of glycosyltransferases,Potential treatment for cancer and inflammatory diseases by inhibiting aberrant glycosylation processes
2012,https://doi.org/10.1371/journal.pone.0043976,Ganglioside mimic,GM1 ganglioside,GM1,"Induces antibodies that may cross-react with neural tissue, contributing to the pathogenesis of Guillain-Barré syndrome (GBS)","Found in the lipo-oligosaccharides (LOS) of C. jejuni strains associated with GBS, indicating a role in immune response"
2012,https://doi.org/10.1371/journal.pone.0043976,Ganglioside mimic,GD1a ganglioside,GD1a,"Similar to GM1, it induces antibodies that may cross-react with neural tissue, contributing to GBS","Detected in the lipooligosaccharide (LOS) of C. jejuni strains related to Guillain-Barré syndrome (GBS), indicating its involvement in triggering an autoimmune response that leads to peripheral nerve damage and acute flaccid paralysis"
2012,https://doi.org/10.1371/journal.pone.0043976,Ganglioside mimic,GA2 ganglioside,GA2,Associated with the immune response in patients with ophthalmoplegia,"Structures mimicking GA2 were found in LOS of C. jejuni strains associated with GBS, suggesting a role in pathogenic antibody formation"
2012,https://doi.org/10.1371/journal.pone.0043976,Ganglioside mimic,GD3 ganglioside,GD3,"Similar to GA2, it is involved in the immune response related to GBS","Structures mimicking GD3 were also found in LOS of C. jejuni strains associated with GBS, indicating their role in inducing pathogenic antibodies"
2012,https://doi.org/10.1093/glycob/cwr140,Carbohydrate-Mimetic Peptides,Methyl α-D-mannopyranoside (a known carbohydrate ligand for Con A).,Con A Ligand-Mimetic Peptides,Serve as ligands for the lectin concanavalin A (Con A).,"Potential applications in antiviral therapy, cancer treatment, and as vaccine components by mimicking carbohydrate antigens and inducing immune responses"
2012,https://doi.org/10.1093/glycob/cwr140,Carbohydrate-Mimetic Peptides,Non-reducing terminal galactose structure.,9-mer Peptides,Recognized by monoclonal antibodies directed to lacto-tetraosylceramide and neolactotetraosylceramide. Bind to Ricinus lectin and inhibit Jack bean β-galactosidase activity toward neolactotetraosylceramide,Potential applications in cancer therapy and treatment of infectious diseases by mimicking carbohydrate antigens and modulating galactose-mediated cellular processes
2012,https://doi.org/10.1093/glycob/cwr140,Carbohydrate-Mimetic Peptides,Lewis Y antigen.,PWLY Peptide,Induces an immune response against the Lewis Y antigen.,"Can elicit an immune response in rabbits and mice, demonstrating its potential as a vaccine component"
2012,https://doi.org/10.1093/glycob/cwr140,Carbohydrate-Mimetic Peptides,Sialyl Lewis X (a carbohydrate ligand).,I-Peptide (IELLQAR),Inhibits the binding of sialyl Lewis X to E-selectin.,"Inhibits lung colonization of melanoma cells, potentially useful for cancer metastasis prevention. May also have applications in treating inflammatory conditions and modulating immune responses."
2012,https://doi.org/10.1093/glycob/cwr140,Carbohydrate-Mimetic Peptides (Epitope analog.),Type III capsular polysaccharide of group B streptococci (GBS).,FDTGAFDPDWPA Peptide,Elicits an antibody response against GBS.,"When conjugated to carriers and used for immunization, it resulted in a significant antibody response to GBS after a single immunization"
2013,https://doi.org/10.1002/ejoc.201201413,Iminosugar,maltose,N-hydroxyethyl-1-deoxy-nojirimycin (Glyset),Glycosidase inhibitor,"Used primarily in the treatment of Type 2 diabetes by inhibiting α-glucosidase, which slows carbohydrate absorption."
2013,https://doi.org/10.1002/ejoc.201201413,Iminosugar,glucosamine,N-butyl-1-deoxy-nojirimycin (Zavesca),Glycosidase inhibitor,"Approved for the treatment of Type 1 Gaucher disease, acting as a pharmacological chaperone for mutant glucocerebrosidase."
2013,https://doi.org/10.1002/ejoc.201201413,Iminosugar,glucose,1-deoxynojirimycin (DNJ),Glycosidase inhibitor,Inhibits various glycosidases and has potential therapeutic applications in metabolic disorders.
2013,https://doi.org/10.1002/ejoc.201201413,Iminosugar,Mannitol,"1,5-dideoxy-1,5-imino-D-mannitol",Glycosidase inhibitor,"Potential treatment for viral infections (HIV, influenza), metabolic disorders (diabetes), and cancer by inhibiting specific glycosidases involved in carbohydrate processing"
2013,https://doi.org/10.1002/ejoc.201201413,Iminosugar,Glucitol (Sorbitol),"1,5-Dideoxy-1,5-imino-D-glucitol",Acts as a glycosidase inhibitor.,"Inhibits enzymes such as α-glucosidases, which are involved in the hydrolysis of glycosidic bonds in carbohydrates. This inhibition can help regulate blood sugar levels, making it useful in the management of diabetes and related metabolic disorders."
2013,https://doi.org/10.1002/ejoc.201201413,Iminosugar,Lyxose,"1,5-Dideoxy-1,5-imino-D-lyxitol",Acts as a glycosidase inhibitor.,"Inhibits glycosidases, which can affect carbohydrate metabolism. Its structural similarity to lyxose allows it to interfere with the enzymatic processes that normally act on this sugar, potentially providing therapeutic benefits in conditions related to carbohydrate metabolism."
2013,https://doi.org/10.1002/ejoc.201201413,Iminosugar,Idohexose,1-Deoxy-1-idonojirimycin (l-DIJ),Glycosidase inhibitor,"Inhibits enzymes involved in carbohydrate metabolism, potentially useful in treating metabolic disorders."
2013,https://doi.org/10.1002/ejoc.201201413,Iminosugar,Pentoses,1-C-alkyl iminopentitols,Glycosidase inhibitor,"Potent inhibitors of β-glucocerebrosidase, showing potential as therapeutic agents for Gaucher disease."
2013,https://doi.org/10.1002/ejoc.201201413,Iminosugar,Mannitol,"1,5,6-trideoxy-1,5-imino-D-mannitol",Glycosidase inhibitor,"Inhibits glycosidases, potentially useful in therapeutic applications."
2013,https://doi.org/10.1002/ejoc.201201413,Iminosugar,Glucitol,"1,5,6-trideoxy-1,5-imino-D-glucitol",Glycosidase inhibitor,"Inhibits glycosidases, impacting carbohydrate metabolism."
2013,https://doi.org/10.1039/C3PY01123B,b-1/6-linked N-acetylglucosamine Oligosaccharide,Polysaccharide intercellular adhesin (PIA) produced by Staphylococcus aureus,Compound 5 (per-acetylated b-1/6-linked N-acetylglucosamine disaccharide),"To create a surface that mimics the natural biofilm structure, enhancing immune recognition.","Potentially immunogenic, may produce anti-PNAG antibodies in vivo, aiding in vaccine development against Staphylococcus aureus infections, particularly biofilm-associated infections"
2013,https://doi.org/10.1039/C3PY01123B,b-1/6-linked N-acetylglucosamine Oligosaccharide,Polysaccharide intercellular adhesin (PIA) produced by Staphylococcus aureus,Oligosaccharides 6-8 (various benzoylated b-1/6-linked glucosamine-based oligosaccharides),Present multiple copies of carbohydrate units to probe multivalent interactions.,"Mimics the globular nodules of PIA, facilitating studies on bacterial adhesion and immune response."
2013,https://doi.org/10.1039/C3PY01123B,Multivalent Constructs,Polysaccharide intercellular adhesin (PIA) produced by Staphylococcus aureus,Multivalent Carbohydrate Constructs,Present multiple copies of carbohydrate units to enhance immune engagement.,"Potential vaccine candidate against Staphylococcus aureus infections by mimicking PIA structure, inducing antibody production, and enhancing immune response against biofilm-associated infections"
2013,https://doi.org/10.1007/128_2013_498,Oligosaccharide Mimetic,Neu5Ac-α(2–3)-Gal-β(1–3)-GalNAc,Neu5Ac-α(2–3)-Gal-β(1–3)-[Neu5Ac-α(2–6)]-GalNAc-β-OSE,"Acts as a high-affinity ligand for MAG, blocking its binding site.","Inhibits MAG (Myelin-Associated Glycoprotein)-mediated neuronal growth inhibition, potentially aiding in nerve regeneration."
2013,https://doi.org/10.1007/128_2013_498,Oligosaccharide Mimetic,Neu5Ac-α(2–3)-Gal-β(1–3)-Gal,Neu5Ac-α(2–3)-Gal-β(1–3)-[Neu5Ac-α(2–6)]-Gal-β-OSE,Designed to mimic the binding characteristics of sialylated gangliosides.,"Competes with natural sialoglycans to disrupt MAG binding, aiding in neuroprotection."
2013,https://doi.org/10.1007/128_2013_498,Oligosaccharide Mimetic,Neu5Ac-α(2–3)-Gal-β(1–3)-GalNAc,Neu5Ac-α(2–3)-Gal-β(1–3)-GalNAc-β-OSE,Serves as a competitive inhibitor for MAG binding.,"Prevents MAG from interacting with its natural ligands, promoting neurite outgrowth."
2013,https://doi.org/10.1007/128_2013_498,Oligosaccharide Mimetic,Neu5Ac-α(2–3)-Gal-β(1–3)-Gal,Neu5Ac-α(2–3)-Gal-β(1–3)-Gal-β-OSE,Mimics the sialylated structure to inhibit MAG interactions.,"Blocks MAG function, potentially aiding in nerve repair and regeneration"
2013,https://doi.org/10.1007/128_2013_498,Oligosaccharide Mimetic,Gal-β(1–3)-[Neu5Ac-α(2–6)]-Gal,Gal-β(1–3)-[Neu5Ac-α(2–6)]-Gal-β-OSE,Designed to block MAG binding through structural similarity.,"Disrupts MAG-mediated inhibition, facilitating neuronal regeneration."
2013,DOI: 10.1248/yakushi.13-00054,α-1-C-alkyl-arabinoiminofuranoses,Various carbohydrates,α-1-C-alkyl-arabinoiminofuranoses,Inhibitor of intestinal maltase and sucrase,"Showed potent inhibitory activities towards intestinal maltase, with IC50 values comparable to commercial drugs such as acarbose, voglibose, and miglitol,which are used in the treatment of type 2 diabetes"
2013,https://doi.org/10.1002/chem.201302786,GM1 mimetics,GM1 ganglioside,Pseudo-tetrasaccharides bearing a cyclohexane diol moiety,Binds to cholera toxin with high affinity,"Potential inhibitor of cholera toxin, which could prevent cholera infection by blocking toxin binding to intestinal cells"
2013,https://doi.org/10.1002/chem.201302786,Non-carbohydrate mimics,GM1 ganglioside,Based on a polyhydroxyalkylfuroic ester structure,Act as antagonists of enterotoxins,Showed binding affinities in the same order as known sugar-derived MNPG; the highest affinity was shown by these non-carbohydrate mimics towards cholera toxin
2013,https://doi.org/10.1002/anie.201302543,Carbocyclic analogue of sergliflozin,"Sergliflozin, which is a glucose analogue",Pseudo-sergliflozin,"Acts as a selective inhibitor of the sodium-dependent glucose cotransporter 2 (SGLT2), responsible for glucose reabsorption in the kidneys.","Pseudo-sergliflozin has a three-fold longer half-life and longer hypoglycemic action compared to sergliflozin-A (2b) in db/db mice, indicating its potential effectiveness as an antidiabetic agent"
2013,https://doi.org/10.1002/anie.201302543,Original sergliflozin compound,Glucose,Sergliflozin-A,"Inhibitor of SGLT2, similar to pseudo-sergliflozin.",Potential treatment for type 2 diabetes by increasing urinary glucose excretion and lowering blood glucose levels without causing hypoglycemia
2014, https://doi.org/10.3762/bjoc.10.17,Carbohydrate memitics,Septanosides,Poly(hydroxy)aminooxepanes derivatives.,Potentially serve as selectin inhibitors and can be used in multivalent conjugates.,Potential therapeutic applications in inflammatory conditions and vascular diseases by inhibiting P- and L-selectin mediated cell adhesion
2014,https://doi.org/10.3389/fimmu.2014.00308,"natural peptides derived from proteins, such as those from the Mucin 1 cell surface receptor (MUC1), which are considered mimics of carbohydrate antigens like the Gal-epitope",Gal-epitope,carbohydrate-mimetic peptides (CMPs),"inducing immune responses to glycan antigens expressed on cancer cells and pathogens, mediating cognate B and T-cell interactions, and potentially functioning as probes to understand the structural basis for the dual recognition properties of antibodies, lectins, and T cells","inducing immune responses that can inhibit tumor growth in vivo, generating antibodies capable of neutralizing pathogens such as HIV-1, and mediating cytotoxic activity against tumor cells."
2014,https://doi.org/10.3762/bjoc.10.182,β-D-2-aminotalose-configured carbohydrate mimetics,"structures related to aminopyrans, which can be associated with various natural carbohydrates, including those with β-D-talose and β-D-idopyranose configurations",phenyl-substituted aminopyrans,"The function of phenyl-substituted aminopyrans includes serving as potential inhibitors for selectins, which are important in cell adhesion processes",Potential anti-inflammatory and anti-metastatic effects due to high binding affinities towards L- and P-selectin when presented in a multivalent format
2014, https://doi.org/10.3762/bjoc.10.182,β-D-2-aminotalose-configured carbohydrate mimetics,structures related to β-D-2-aminotalose and β-D-2-aminoidose,rigid divalent p-terphenyl-linked carbohydrate mimetics,"the function of these mimetics includes serving as potential inhibitors for selectins, which are important in cell adhesion processes","The activity of rigid divalent p-terphenyl-linked carbohydrate mimetics is highlighted by their ability to exhibit high binding affinities towards L- and P-selectin when presented in a multivalent format, indicating their potential biological activity ."
2014, https://doi.org/10.3762/bjoc.10.182,β-D-2-aminoidose-configured carbohydrate mimetics,mimic structures related to β-D-2-aminotalose and β-D-2-aminoidose,divalent compounds with p-terphenyl spacers,"the function of these mimetics includes serving as potential inhibitors for selectins, which are important in cell adhesion processes",Potential anti-inflammatory and anti-metastatic effects due to high binding affinities towards L- and P-selectin when presented in a multivalent format
2014, https://doi.org/10.3762/bjoc.10.182,Unnatural divalent rigid p-terphenyl-linked C-aryl glycosides,structures related to β-D-2-aminotalose and β-D-2-aminoidose,biphenyl aminopyran,"the function of these mimetics includes serving as potential inhibitors for selectins, which are important in cell adhesion processes",Potential anti-inflammatory and anti-metastatic effects due to high binding affinities towards L- and P-selectin when presented in a multivalent format
2014, https://doi.org/10.3762/bjoc.10.182,Unnatural divalent rigid p-terphenyl-linked C-aryl glycosides,structures related to β-D-2-aminotalose and β-D-2-aminoidose,p-terphenyl-linked dimers,"the function of these mimetics includes serving as potential inhibitors for selectins, which are important in cell adhesion processes",Potential anti-inflammatory and anti-metastatic effects due to high binding affinities towards L- and P-selectin when presented in a multivalent format
2014, https://doi.org/10.3762/bjoc.10.182,carbohydrate mimetics that combine features of C-aryl glycosides and aminosugars,structures related to β-D-2-aminotalose and β-D-2-aminoidose,Aminosugar Mimetics,"the function of these mimetics includes serving as potential inhibitors for selectins, which are important in cell adhesion processes",Potential inhibition of selectin-mediated cell adhesion
2014,https://doi.org/10.1002/ejoc.201402191,carbohydrate mimetics.,natural carbohydrate Sialyl Lewis X.,"Sialyl Lewis X (sLe x) analogues
",these analogues have the potential to be used for the treatment of diseases such as chronic inflammations.,"They are involved in high binding affinities towards L- and P-selectins, which are important in cell adhesion processes"
2014,https://doi.org/10.1002/ejoc.201402191,carbohydrate mimetics.,Septanosides,Poly(hydroxy)aminooxepanes,"The function of poly(hydroxy)aminooxepanes is to serve as building blocks for the synthesis of various compounds, including those considered as carbohydrate mimetics","Potential therapeutic applications in inflammatory conditions and vascular diseases by inhibiting P- and L-selectin mediated cell adhesion. May have interesting biological activities, possibly as selectin inhibitors."
2014,https://doi.org/10.1002/ejoc.201402191,carbohydrate mimetics.,Septanosides,Azidooxepanes,Azidooxepanes serve as intermediates in the synthesis of various carbohydrate mimetics through copper-catalyzed [3+2] cycloadditions with alkynes,"Potential applications in drug discovery and development of new therapeutics for inflammatory conditions and vascular diseases. The resulting triazole-containing compounds may exhibit biological activities similar to carbohydrates, possibly as enzyme inhibitors or receptor ligands."
2014,https://doi.org/10.1002/ejoc.201402191,carbohydrate mimetics.,Septanosides,Triazole derivatives,"Triazole derivatives can serve as potential inhibitors in biological processes, particularly in relation to selectin interactions.","They exhibit high binding affinities towards L- and P-selectins, which are important in cell adhesion processes"
2014,https://doi.org/10.1002/ejoc.201402191,carbohydrate mimetics.,Septanosides,Divalent oxepane,"The divalent structure, along with its long flexible spacer and terminal aryl groups, shows resemblance to known selectin inhibitors, such as Bimosiamose, which have been developed for clinical studies","They exhibit high binding affinities towards L- and P-selectins, which are important in cell adhesion processes"
2014,https://link.springer.com/chapter/10.1007/7355_2014_50,Iminosugar,glucose mimetic based on its scaffold,deoxynojirimycin,Modulates the action of enzymes involved in carbohydrate synthesis and metabolism.,Demonstrated activity in inhibiting glucocerebrosidase and has been associated with therapeutic applications for lysosomal storage diseases
2014,https://link.springer.com/chapter/10.1007/7355_2014_50,Iminosugar,mannose,swainsonine,"Modulates the action of enzymes involved in carbohydrate synthesis and metabolism, specifically as an inhibitor of α-mannosidase.","1. Potential anti-cancer agent: Inhibits tumor cell growth, reduces metastasis, and enhances cellular immune responses"
2014,https://link.springer.com/chapter/10.1007/7355_2014_50,Iminosugar,glucose,castanospermine,"Modulates the action of enzymes involved in carbohydrate synthesis and metabolism, specifically as an inhibitor of glucosidases","Demonstrated activity in inhibiting glucosidases, which is relevant for therapeutic applications in lysosomal storage diseases"
2014,https://link.springer.com/chapter/10.1007/7355_2014_50,Iminosugar,glucose,nojirimycin,Modulates the action of enzymes involved in carbohydrate synthesis and metabolism,"Potential treatment for viral infections (HIV, influenza), diabetes, and cancer by inhibiting specific glycosidases"
2014,https://link.springer.com/chapter/10.1007/7355_2014_50,Iminosugar,glucose,isofagomine,"act as a pharmacological chaperone for the glucocerebrosidase enzyme, which is relevant for the treatment of Gaucher’s disease","Potential treatment for Gaucher's disease by stabilizing mutant glucocerebrosidase, enhancing its trafficking to lysosomes, and increasing its enzymatic activity"
2014,https://link.springer.com/chapter/10.1007/7355_2014_50,Iminosugar,glucose,miglitol,"Miglitol is used for the treatment of Type II diabetes and functions by inhibiting carbohydrate-processing enzymes, which helps to regulate blood sugar levels","Inhibits alpha-glucosidase enzymes, delaying carbohydrate digestion and reducing postprandial hyperglycemia"
2014,https://link.springer.com/chapter/10.1007/7355_2014_50,Iminosugar,glucose,miglustat,"It functions by inhibiting glucosylceramide synthase, which helps to reduce the accumulation of glucosylceramide in lysosomes","Miglustat is used for the treatment of lysosomal storage diseases, specifically Gaucher’s disease and Niemann Pick type C disease."
2014,https://link.springer.com/chapter/10.1007/7355_2014_50,Iminosugar,mannose,nojirimycin B,Modulates the action of enzymes involved in carbohydrate synthesis and metabolism.,Potential antiviral and antitumor agent by interfering with N-linked glycosylation
2014,https://link.springer.com/chapter/10.1007/7355_2014_50,Iminosugar,galactose,galactostatin,Inhibitor of β-galactosidase.,Potential treatment for GM1-gangliosidosis and Morquio B disease by acting as a pharmacological chaperone for lysosomal β-galactosidase
2014,https://link.springer.com/chapter/10.1007/7355_2014_50,Iminosugar,glucose,moranoline,Modulates the action of enzymes involved in carbohydrate synthesis and metabolism.,"Potential treatment for diabetes by inhibiting intestinal α-glucosidases, reducing postprandial glucose levels"
2014,https://link.springer.com/chapter/10.1007/7355_2014_50,Iminosugar,glucose,fagomine,Modulates the action of enzymes involved in carbohydrate synthesis and metabolism.,"Lowers postprandial blood glucose and modulates bacterial adhesion, potential for diabetes management and gut health"
2014,https://link.springer.com/chapter/10.1007/7355_2014_50,Iminosugar,pyranose sugars,Alexines,Modulates the action of enzymes involved in carbohydrate synthesis and metabolism.,Potential treatment for lysosomal storage disorders and as antiviral agents by inhibiting ER α-glucosidases
2014,https://link.springer.com/chapter/10.1007/7355_2014_50,Iminosugar,D-galactose,Casuarine,"inhibits glycosidases, specifically targeting enzymes like α-galactosidase.",Potential treatment for Fabry disease and other lysosomal storage disorders by inhibiting α-galactosidase
2014,https://doi.org/10.1517/17425247.2014.902048,Glycopolymers,"Naturally occurring polysaccharides (e.g., glycosaminoglycans, chondroitin sulfate)",Glycopolymers,"Anticoagulant, anti-inflammatory, anti-tumor properties","Potential applications in treating cardiovascular diseases, inflammatory conditions, and cancer by mimicking biological activities of natural polysaccharides. May also be used as drug delivery systems and protein stabilizers in pharmaceutical formulations."
2014,https://doi.org/10.1517/17425247.2014.902048,Glyconanoparticles,Glycans in lipid rafts,Glyconanoparticles (GNPs),"Targeted drug delivery, gene therapy, vaccine development","Engages in carbohydrate-protein and carbohydrate-carbohydrate interactions, shows promise for clinical applications"
2014,https://doi.org/10.4161/hv.34300,Carbohydrate Mimetic Peptide (CMP),Lewis Y (LeY) carbohydrate antigens,P10s,Induces anti-tumor antibody response and is hypothesized to interfere with cellular pathways involved in tumor cell survival.,"The P10s vaccine resulted in responses to P10s, with serum and plasma antibodies that were reactive with and cytotoxic to human breast cancer cells in vitro, including a Trastuzumab-resistant cell line. It also suggested sensitization of tumor cells for more efficient killing upon administration of chemotherapy (docetaxel)"
2014,https://doi.org/10.1021/ol500848q,Acyclic form derivatives,Acyclic intermediate of UDP-Gal f,UDP-galactitols (specifically molecules 8 and 9),Designed to mimic the acyclic form of galactitol to inhibit UGM.,"Potential antimycobacterial agent by inhibiting UGM, which is essential for mycobacterial cell envelope biosynthesis. May be effective against pathogens like Mycobacterium tuberculosis and drug-resistant Corynebacterium diphtheriae"
2014,https://doi.org/10.1021/ol500848q,C-glycosidic analogue,UDP-galactofuranose,UDP-C-Galf (20),Used for comparison in inhibition studies against UGM,"Potential antimycobacterial agent, but less effective than UDP-carbasugar 7 in inhibiting UGM, which is essential for mycobacterial cell wall biosynthesis. May have limited efficacy in treating tuberculosis and related infections due to weaker affinity for UGM"
2014,https://doi.org/10.1021/ol500848q,Transition-state analogue,Mimics high-energy intermediates of the UGM-catalyzed reaction,UDP-carbasugar (7),Designed to act as a high-energy intermediate analogue for UGM inhibition.,"Potential antimycobacterial agent by inhibiting UGM, which is essential for mycobacterial cell wall biosynthesis, particularly in treating tuberculosis and related infections"
2014,https://doi.org/10.1517/13543776.2014.916280,Amino Carbasugar,D-Glucose,Valienamine,Glycosidase inhibitor,"Inhibits α-glucosidases and is the active pharmacophore in acarbose, used to treat type 2 diabetes"
2014,https://doi.org/10.1517/13543776.2014.916280,Amino Carbasugar,D-Glucose,Acarbose,α-Glucosidase inhibitor,Used as an anti-diabetic drug to slow carbohydrate absorption in the intestine
2014,https://doi.org/10.1517/13543776.2014.916280,Iminosugar,D-Mannose,Mannojirimycin,"Inhibits α-mannosidases, which can affect glycoprotein processing.",. Potential antiviral agent against HIV and other viruses by interfering with N-linked glycosylation. May also have applications in treating lysosomal storage disorders and as an anti-inflammatory agent in cystic fibrosis.
2014,https://doi.org/10.1517/13543776.2014.916280,Thiosugar,D-Mannose,5-thio-D-mannose (Thiosugar),Glycosidase inhibitor,"Inhibits glycosidases, potentially affecting carbohydrate metabolism"
2014,https://doi.org/10.1517/13543776.2014.916280,Iminosugar,D-Mannitol,"2,5-Dideoxy-2,5-imino-D-mannitol (DMDP)",Glycosidase inhibitor,"Potential antiviral (HIV, influenza), antituberculosis, and antidiabetic agent. May also have applications in treating Gaucher's disease and as an insect antifeedant"
2014,https://doi.org/10.1517/13543776.2014.916280,Iminosugar,D-Galactose,Migalastat (Amigal),Pharmacological chaperone,"Used in the treatment of Fabry disease, Migalastat stabilizes the mutant form of the enzyme α-galactosidase A, enhancing its activity and helping to reduce substrate accumulation"
2014,https://doi.org/10.1517/13543776.2014.916280,Bicyclic Iminosugar,D-Glucose,Australine,Glycosidase inhibitor,"Isolated from Castanospermum australe, Australine has shown glycosidase inhibitory activity and potential antiviral properties"
2014,https://doi.org/10.1021/jo402574h,Bicyclic hybrid,Monosaccharide,Bicyclic diazasugar (9),Glycosidase inhibitor,"Potential treatment for metabolic disorders, viral infections, and cancer by inhibiting specific glycosidases involved in carbohydrate processing. May also have applications in treating lysosomal storage disorders by acting as a pharmacological chaperone"
2014,https://doi.org/10.1021/jo402574h,Hybrid molecule,Resembles sugars,Sugar−piperidine hybrid (5),Glycosidase inhibitor,Potential treatment for Gaucher disease and other lysosomal storage disorders by selectively inhibiting β-glucosidase (IC50 = 38.8 μM). May act as a pharmacological chaperone to stabilize mutant glucocerebrosidase enzymes and improve their trafficking to lysosomes.
2014,https://doi.org/10.1021/jo402574h,Hybrid molecule,Resembles sugars,Sugar−pyran derivative (25a),Glycosidase inhibitor,Potential treatment for GM1 gangliosidosis and related lysosomal storage disorders by inhibiting β-galactosidase (IC50 = 36.5 μM). May act as a pharmacological chaperone to stabilize mutant enzymes and improve their trafficking to lysosomes.
2014,https://doi.org/10.1021/jo402574h,Hybrid molecule,Resembles sugars,Sugar−piperidine derivative (20a),Glycosidase inhibitor,Potential treatment for Gaucher disease and other lysosomal storage disorders by selectively inhibiting β-glucosidase (IC50 = 38.8 μM). May act as a pharmacological chaperone to stabilize mutant glucocerebrosidase enzymes and improve their trafficking to lysosomes.
2015,https://doi.org/10.3762/bjoc.11.72,Divalent carbohydrate mimetics,Based on aminopyran and serinol,Divalent carbohydrate mimetics connected to carboxylic acid cores by amide bonds derived from aminopyran and serinol,"These mimetics are designed to act as inhibitors of selectins, which are crucial in the inflammatory process.","The divalent amide showed surprisingly good activities with IC50 values in the micromolar range, indicating potential effectiveness as L-selectin inhibitors for treating inflammatory conditions"
2015,https://doi.org/10.3762/bjoc.11.72,Trivalent carbohydrate mimetics,Based on aminopyran and serinol,Trivalent carbohydrate mimetics connected to carboxylic acid cores by amide bonds derived from aminopyran and serinol,"These mimetics are designed to act as inhibitors of selectins, which are crucial in the inflammatory process.",Micromolar IC50 values suggest potential as L-selectin inhibitors for treating inflammatory conditions
2015,https://doi.org/10.1002/ejoc.201403186,C-Glycosides,D-talose,Aryl C-glycosides,"Enhanced stability against enzymatic degradation
Improved oral bioavailability","Potential anticancer, antioxidant, antiviral, and hypoglycemic effects; May act as enzyme inhibitors for various diseases"
2015,https://doi.org/10.1002/ejoc.201403186,C-Glycosides,D-talose.,"Bicyclic 1,2-oxazines","Enhanced stability against enzymatic degradation
Improved oral bioavailability","Potential anticancer, antioxidant, antiviral, and hypoglycemic effects; May act as enzyme inhibitors for various diseases"
2015,https://doi.org/10.1002/ejoc.201403186,Aminopyrans,Sialyl Lewis X,O-sulfated aminopyrans,Mimic carbohydrate structures involved in cell adhesion,"Extremely high binding affinities towards L- and P-selectin, with potential applications in treating chronic inflammation (e.g., asthma)"
2015,https://doi.org/10.1002/ejoc.201403186,Sialyl Lewis X Analogs,Sialyl Lewis X,Synthetic analogs of sialyl Lewis X,Inhibit selectin-mediated cell adhesion,Potential therapeutic agents for inflammatory diseases
2015,http://dx.doi.org/10.1055/s-0034-1380201., N-alkylated compounds,Pyranose,"Secondary amine 9, obtained from the reaction of aminopyran with pentanal",Potential glycosidase inhibitor,May help in managing metabolic disorders like diabetes by regulating carbohydrate digestion
2015,http://dx.doi.org/10.1055/s-0034-1380201., N-alkylated compounds,Pyranose,"Secondary amine 10, obtained from the reaction of aminopyran with benzaldehyde",Potential glycosidase inhibitor,May help in managing metabolic disorders like diabetes by regulating carbohydrate digestion
2015,http://dx.doi.org/10.1055/s-0034-1380201., N-alkylated compounds,Pyranose,"Secondary amine 11, obtained from the reaction of aminopyran with 4-bromobenzaldehyde",Potential glycosidase inhibitor,May help in managing metabolic disorders like diabetes by regulating carbohydrate digestion
2015,https://doi.org/10.1002/chem.201500831,Carbohydrate mimetic,Neuraminic acid,Zanamivir (Relenza),Targets influenza viral neuraminidase,Antiviral activity against influenza viruses
2015,https://doi.org/10.1002/chem.201500831, Carbohydrate mimetic,Neuraminic acid,Oseltamivir (Tamiflu),Targets influenza viral neuraminidase,Antiviral activity against influenza viruses
2015,https://doi.org/10.1002/chem.201500831,Glycolipid mimic,a-GalCer,Synthetic C-glycoside analogues of a-GalCer glycolipid,Stimulates human NKT cells,activity in malaria and melanoma models
2015,https://doi.org/10.1002/bmb.20915,Dimeric Aminoglycosides,natural carbohydrates,Dimeric Aminoglycosides,"The primary function of these dimeric aminoglycosides is to inhibit the interaction between the HIV Trans-activator of transcription (Tat) protein and the Trans Activation Responsive (TAR) RNA. This interaction is crucial for the activation of transcription in the HIV life cycle, making it a valuable target for therapeutic intervention.","The activity of these carbohydrate-based dimeric target molecules lies in their ability to block the Tat-TAR interaction, thereby exerting antiviral effects. The inhibition of this interaction can potentially prevent the replication of the virus, contributing to therapeutic strategies against HIV."
2015,https://doi.org/10.1016/j.toxicon.2015.08.003,Carbohydrate receptor mimic,Galactose-containing carbohydrates,Lactulose (LAU),"Inhibits the oral toxicity of botulinum neurotoxin A (BoNT/A) by binding to the HA complex, preventing it from compromising the integrity of epithelial cell monolayers and blocking internalization.",Demonstrated protective effects against BoNT/A oral intoxication in vivo
2015,https://doi.org/10.1016/j.toxicon.2015.08.003,Non-metabolizable Gal analog,Galactose,Iso-propyl β-D-1-thiogalactopyranoside (IPTG),Inhibits the oral toxicity of BoNT/A by competing with endogenous carbohydrate receptors on the cell surface,Significantly extended the median survival time of mice in oral intoxication models
2015,https://doi.org/10.1016/j.copbio.2014.11.016,Synthetic Lectin,Glucose and its epimers,Boronic Acid-Based Receptors,These receptors utilize boronate ester formation to bind carbohydrates.,Potential applications in diabetes monitoring and management through selective glucose sensing. May also have uses in developing targeted drug delivery systems or diagnostic tools for diseases involving altered glucose levels or metabolism.
2015,https://doi.org/10.1016/j.copbio.2014.11.016,Synthetic Receptor,Equatorial glucosides,Tripodal Benzene Receptors,Designed to bind equatorial glucosides using noncovalent interactions.,Exploitable for targeted drug delivery and carbohydrate sensing
2015,https://doi.org/10.1016/j.copbio.2014.11.016,Synthetic Receptor,All-equatorial carbohydrates,Temple Receptors,These receptors are structured to bind carbohydrates effectively using a combination of hydrophobic and polar interactions.,"Potential for targeted drug delivery, cellular imaging, or carbohydrate-based therapeutics for diseases"
2015,https://doi.org/10.1016/j.copbio.2014.11.016,Synthetic Receptor,Beta-mannosides,Pyrrolic Tripodal Receptor,Specifically recognizes beta-mannosides.,"Potential for targeted drug delivery, biosensing, and diagnostic applications related to mannoside-mediated processes. May be used to target cancer cells that overexpress mannose receptors or to modulate immune responses."
2015,https://doi.org/10.1021/acs.orglett.5b02223,S-linked hexasaccharide,Hexasaccharide subunit of landomycin A,S-linked hexasaccharide of landomycin A,Designed to be resistant to acid-mediated or enzymatic hydrolysis,"The mimetic is associated with antitumor activity against cancer cell lines, as landomycin A possesses a broad spectrum of antitumor activity"
2015,http://dx.doi.org/10.1517/17460441.2015.1067198,Adjuvant,"Trehalose-6,6'-dibehenate (TDB)",Trehalose,Adjuvant in vaccine formulations.,"Enhances immune responses, particularly in tuberculosis vaccines."
2015,https://doi.org/10.1002/chem.201500831,Glycomimetic drug,Sialyl Lewis x (sLe^x),GMI-1070 (Rivipansel),Potent pan-selectin antagonist,Reverses vaso-occlusion in sickle cell disease and is in clinical trials for this condition
2015,https://doi.org/10.1002/chem.201500831,Glycomimetic drug,Sialyl Lewis x (sLe^x),GMI-1271,Specific E-selectin inhibitor,Evaluated in clinical trials in combination with chemotherapy for treating acute myeloid leukemia
2015,https://doi.org/10.1002/chem.201500831,Synthetic carbohydrate mimic,2G12 epitope,Unnatural oligomannose mimics,Targeting high-mannose epitopes for immune response,aimed at improving immune response against HIV.
2015,https://doi.org/10.1002/chem.201500831,Glycomimetic compound,Sialic acid,High-affinity sialic acid mimetics,Inhibitor of myelin-associated glycoprotein (MAG),Promotes neurite outgrowth; potential therapeutic applications in neuronal repair and spinal cord injury.
2015,https://doi.org/10.1002/chem.201500831,Synthetic glycoprotein mimic,Glycan structures found on PSGL-1,Synthetic P-selectin–glycoprotein–ligand-1 (PSGL-1) mimics,Diagnostic probe for in vivo inflammatory brain damage,Used for detection of early P-selectin expression in inflammatory brain lesions and cerebral malaria pathology in mice.
2015,https://doi.org/10.1002/chem.201500831,Glycan-based therapeutic,Various carbohydrate structures (often mimicking natural glycan epitopes),Multivalent Glycoconjugates,Designed to enhance affinity for protein targets by mimicking the multivalent nature of interactions between lectins and their natural carbohydrate ligands,"Developed to improve the overall affinity of glycan therapeutics, with examples including glycodendrimers and glycoclusters."
2016,https://doi.org/10.1021/acs.joc.6b00302,Fluorinated Carbohydrate Mimic,D-threo-hexopyranose,"2,3-dideoxy -2,2,3,3-tetrafluoro D -thereo hexopyranose",Potential inhibitor of carbohydrate-processing enzymes,"May have therapeutic potential in treating diseases involving carbohydrate metabolism, such as diabetes or viral infections"
2016,https://doi.org/10.1021/acs.joc.6b00302,Fluorinated Carbohydrate Mimic,D-threo-hexofuranose,"2,3-dideoxy -2,2,3,3-tetrafluoro D -thereo hexofuranose",Potential inhibitor of carbohydrate-processing enzymes,"May have therapeutic potential in treating diseases involving carbohydrate metabolism, such as diabetes or viral infections"
2016,https://doi.org/10.1021/acs.joc.6b00302,Fluorinated Carbohydrate Mimic,D-erythro-hexopyranose,"2,3-dideoxy -2,2,3,3-tetrafluoro D -erythro hexopyranose",Potential inhibitor of carbohydrate-processing enzymes,"May have therapeutic potential in treating diseases involving carbohydrate metabolism, such as diabetes or viral infections"
2016,https://doi.org/10.1021/acs.joc.6b00302,Fluorinated Carbohydrate Mimic,D-threo-hexopyranose,"3,4-dideoxy -3,3,4,4-tetrafluoro D -threo hexopyranose",Potential inhibitor of carbohydrate-processing enzymes,"May have therapeutic potential in treating diseases involving carbohydrate metabolism, such as diabetes or viral infections"
2016,https://doi.org/10.1021/acs.joc.6b00302,Fluorinated Carbohydrate Mimic,D-erythro-hexopyranose,"3,4-dideoxy -3,3,4,4-tetrafluoro D -erythro hexopyranose",Potential inhibitor of carbohydrate-processing enzymes,"May have therapeutic potential in treating diseases involving carbohydrate metabolism, such as diabetes or viral infections"
2016,https://doi.org/10.1021/acs.joc.6b00302,Fluorinated Nucleotide Sugar Mimetics,UDP-Galactose (UDP-Gal),dideoxy-tetrafluorinated uridine diphosphate (UDP)-Gal analogues,Inhibitor of the enzyme UDP-galactopyranose mutase (UGM),Potential antimycobacterial agent with improved activity against tuberculosis
2016,DOI: 10.1016/j.tibtech.2016.01.004,Fucose-based glycomimetic,Lewis X oligosaccharide,α-fucosyl-β-alanyl amide,Targets DC-SIGN without inducing dendritic cell maturation and IL-10 production,"Acts as a potent DC-SIGN targeting device, suggesting potential use in targeted imaging or antigen delivery"
2016,DOI: 10.1016/j.tibtech.2016.01.004,Mannose-based glycomimetic,"1,2-mannobioside and linear Man-α-1,2-Man-α-1,6-Man trisaccharide",Mannose-based glycomimetic antagonists,Antagonists of protein-sugar interactions,Effective in hampering microbial adhesion
2016,https://doi.org/10.1016/j.cbpa.2016.08.027,Non-natural sugar,N-acetylglucosamine,GlcNAz (N-acetylglucosamine azide),Metabolically incorporated into cells for labeling and detection.,Used in glycobiology research to study glycosylation processes in cancer and immune responses
2016,https://doi.org/10.1016/j.cbpa.2016.08.027,Non-natural sugar,N-acetylmannosamine,ManNAz (N-acetylmannosamine azide),Metabolically incorporated into cells.,Used in glycobiology research to study glycosylation processes in cancer and immune responses
2016,https://doi.org/10.1016/j.cbpa.2016.08.027,Non-natural sugar,N-acetylgalactosamine,GalNAz (N-acetylgalactosamine azide),Metabolically incorporated into cells.,Facilitates the labeling of glycoproteins and tracking of glycosylation
2016,https://doi.org/10.1016/j.cbpa.2016.08.027,Non-natural sugar,N-acetylmannosamine,ManNAl (N-acetylmannosamine alkyne),Used for metabolic incorporation and subsequent 'click' reactions.,Allows for the study of cell surface glycans and their role in diseases
2016,https://doi.org/10.1016/j.cbpa.2016.08.027,Non-natural sugar,N-acetylmannosamine,ManNCyoc (N-acetylmannosamine cyano),Metabolically incorporated into cells.,"Used in studies of glycosylation and cellular interactions, impacting diseases processes"
2016,https://doi.org/10.1016/j.cbpa.2016.08.027,Non-natural sugar,N-acetylmannosamine,ManNMCp (N-acetylmannosamine methylcyclopropene),Metabolically incorporated into cells.,Facilitates the study of glycosylation patterns
2016,https://doi.org/10.1016/j.cbpa.2016.08.027,Non-natural sugar,N-acetylmannosamine,ManNCp (N-acetylmannosamine cyclopropene),Used for metabolic incorporation.,Allows for the tracking of modified glycans in the context of cancer and other diseases
2016,https://doi.org/10.1016/j.cbpa.2016.08.027,Non-natural sugar,Sialic acid,BCNSia (a specific sialic acid mimic),Used in studies of glycosylation.,Helps in understanding the role of sialylation in cellular processes related to cancer and immune responses
2016,https://doi.org/10.1016/j.cbpa.2016.08.027,Nucleotide sugar,Xylose,UDP-4-XylAz (uridine diphosphate 4-xylose azide),Used for metabolic incorporation into glycan structures.,Facilitates the study of glycan biosynthesis
2016,https://doi.org/10.1016/j.cbpa.2016.08.027,Non-natural sugar,Glucosamine,GlcN-n-Iso ,Used for metabolic incorporation into cellular processes.,"it can be utilized in studies related to glycosylation and may serve as a tool for investigating glycan interactions and modifications in biological systems, particularly within cancer cells."
2016,https://doi.org/10.1021/acs.joc.6b01876,Carbasugar,α-Galactose,(−)-MK7607,Potent herbicidal activity,"Isolated from the cultures of Curvularia eragrostidis D2452, it has considerable interest due to its herbicidal properties"
2016,https://doi.org/10.1021/acs.joc.6b01876,Carbasugar,Cyclitol,(−)-Epoxydine B,Glycosidase inhibitor,"Exhibits antibacterial, antifungal, and antialgal  activities; potential for treating infections"
2016,https://doi.org/10.1021/acs.joc.6b01876,Carbasugar,Cyclitol,(−)-Epoxydine C,Glycosidase inhibitor,"Exhibits antibacterial, antifungal, and antialgal  activities; potential for treating infections"
2017,https://doi.org/10.1021/acscentsci.7b00214,irreversible glycosidase inhibitors,α-glucosidase,"1,6-Epi-Cyclophellitol Cyclosulfate (α-cyclosulfate)","Cyclophellitol cyclosulfates are designed to mimic the carbohydrate substrate of α-glucosidases, acting as inhibitors of these enzymes",Potent nanomolar α-glucosidase inhibitor with potential therapeutic applications in treating lysosomal storage disorders and other diseases involving α-glucosidase activity
2017,https://doi.org/10.1021/acscentsci.7b00214,irreversible glycosidase inhibitors,α-glucosidase,"1,6-Cyclophellitol Cyclosulfate (β-cyclosulfate)","Cyclophellitol cyclosulfates are designed to mimic the carbohydrate substrate of α-glucosidases, acting as inhibitors of these enzymes","Modest inhibitor of β-glucosidases with potential applications in treating Gaucher disease and other lysosomal storage disorders, albeit less effective than α-cyclosulfate"
2017,https://doi.org/10.1021/acscentsci.7b00214,β-glucosidase inhibitors.,"β-Glucose substrates in their transition state, specifically the 4H3 conformation adopted by retaining β-glucosidase substrates.",Cyclophellitol Aziridine,"Mimics the transition state of β-glucose substrates to bind and inhibit β-glucosidases. Forms a covalent adduct with the enzyme, leading to permanent inhibition through nucleophilic attack and ring opening.","Potential treatment for lysosomal storage disorders, particularly Gaucher disease, by inhibiting glucocerebrosidase (GBA1) and non-lysosomal glucosylceramidase (GBA2)"
2017,https://doi.org/10.1002/chem.201703129,"five-membered heterocycles containing one double bond, 
one oxygen and one phosphorus atom",Furanose carbohydrate,"Oxaphospholenes 
3-4",serve as precursors for furanose carbohydrate mimics,Potential applications in developing anti-cancer and anti-diabetic drugs by mimicking furanose-based enzyme substrates or inhibitors
2017,https://doi.org/10.1039/C7OB00386B,Glycolipid mimetics,Monosaccharides,Penaresidins,"Actomyosin ATPase activator, potential biomarker","Cytotoxicity against cancer cell lines, potential biomarker for cervical cancer, antimicrobial activity against Mycobacterium tuberculosis"
2017,https://doi.org/10.1039/C7OB00386B,Glycolipid mimetics,Monosaccharides,Penazetidine A,Protein kinase C inhibitor,"Cytotoxicity against human and murine cell lines (A549, HT-29, B16/F10, P388), potential anticancer activity"
2017,https://doi.org/10.1039/C7OB00386B,Nucleoside analogue,guanosine,Oxetanocin A,Inhibits viral DNA polymerases and reverse transcriptases,"Potent antiviral activity against HIV, HSV-1, HSV-2, and HCMV; potential antitumor and antibacterial properties"
2017,https://doi.org/10.1039/C7OB00386B,Glycoside analogue,Monosaccharides,Oxetanosides,Related to the synthesis of oxetanocin A and its analogues.,"Potential antiviral, antitumor, and antibacterial activities"
2017,https://doi.org/10.1039/C7OB00386B,Nitrogen-containing square sugars,Monosaccharides,Azetidine-based sugars,"Designed as constrained analogues of iminosugars, which are a major class of carbohydrate mimics.","Some azetidine derivatives have shown biological activities, including inhibition of enzymes like E. coli β-glucuronidase"
2017,https://doi.org/10.1039/C7OB00386B,Azetidine-based sugar,Monosaccharides,Azetidinol,Inhibits β-N-acetylhexosaminidases,Potential treatment for lysosomal storage disorders like Tay-Sachs disease
2017,https://doi.org/10.1039/C7OB00386B,Azetidine derivative,Monosaccharides,Bicyclic azetidine,Amyloglucosidase inhibitor,Potential treatment for diabetes by regulating carbohydrate digestion
2017,https://doi.org/10.1039/C7OB00386B,Thietanose analogue,furanose sugars,Thietanose,Designed as a carbohydrate mimic with potential applications in organic chemistry.,Potential anti-HIV activity
2017,https://doi.org/10.1039/C7OB00386B,Thiethane analogue,furanose sugars,Pseudothietanose,Related to the synthesis of thietanose analogues.,Potential anti-HIV activity
2017,https://doi.org/10.1039/C7OB00386B,Cyclobutane derivatives,Monosaccharides,Highly-functionalized cyclobutanes,Explored for their potential in medicinal chemistry.,"May improve drug properties such as metabolic stability and conformational restriction, with potential applications in various diseases including cancer, viral infections, and neurodegenerative disorders"
2017,https://doi.org/10.1080/1040841X.2016.1242868,Iminosugar,Deoxynojirimycin (DNJ),"N-butyl-deoxynojirimycin (N B-DNJ, Miglustat)",Inhibitor of glycosphingolipid biosynthesis and glucosidases,"Used in the treatment of type I Gaucher disease and Niemann-Pick type C disease; has demonstrated antiviral activity against various viruses, including HIV-1 and DENV"
2017,https://doi.org/10.1080/1040841X.2016.1242868,Iminosugar,Deoxynojirimycin (DNJ),N-hydroxyethyldeoxynojirimycin (Miglitol),Inhibitor of glucosidases,Used in the treatment of non-insulin-dependent diabetes
2017,https://doi.org/10.1080/1040841X.2016.1242868,Iminosugar,Castanospermine,6-O-butanoyl castanospermine (BuCAST),Inhibitor of glycosphingolipid biosynthesis and glucosidases,Reduced murine brain viral load of herpes simplex virus type 1 (HSV-1) following cutaneous infection; tested in vivo against a range of influenza virus strains with reduced pathology and increased survival in murine lethal infection models
2017,https://doi.org/10.1080/1040841X.2016.1242868,Iminosugar,Sialic acid,3-episiastatin B,Neuraminidase inhibitor,Potent inhibitory activities against influenza virus neuraminidases and influenza virus infection
2017,https://doi.org/10.1080/1040841X.2016.1242868,Iminosugar,Deoxynojirimycin (DNJ),N-nonyl-deoxynojirimycin (N N-DNJ),Inhibitor of glycosphingolipid biosynthesis and glucosidases,Reduced secretion of glycoproteins E and NS1 and virion production in dengue virus (DENV) and Japanese encephalitis virus (JEV); reduced mortality rate in a JEV mouse lethal challenge model
2017,https://doi.org/10.1080/1040841X.2016.1242868,Iminosugar,Deoxynojirimycin (DNJ),N-(9-methoxynonyl)-1-deoxynojirimycin (M O N-DNJ),Inhibitor of glycosphingolipid biosynthesis and glucosidases,Demonstrated protective effects against lethal doses of H1N1 influenza viruses and reduced mortality rate in a mouse lethal challenge model
2017,https://doi.org/10.1016/j.carres.2017.03.012,Inositol Mimic,L-rhamnopyranose,D-pinitol,Potential sugar substitute,Potential applications in diabetes management due to its insulin-like effects and in treating polycystic ovary syndrome
2017,https://doi.org/10.1016/j.carres.2017.03.012,Azasugars,Various sugars,Azasugars,Inhibition of glycosidases,Used in treatments for type 1 Gaucher disease (Zavesca®) and type II diabetes (Glyset)
2017,https://doi.org/10.1016/j.carres.2017.03.012,Carbasugars,Various sugars,Carbasugars,"Enhanced biostability and inhibition of specific enzymes (e.g., Ser/Thr protein kinase, SGLT2, heparanase)","Potential treatments for cancer, diabetes, and inflammatory diseases due to their increased chemical stability and specific enzyme inhibition"
2017,https://doi.org/10.1016/j.carres.2017.03.012,Inositol Mimic,Rhamnopyranoside residue of a trisaccharide,Inositol Analogues,Potential use in synthetic vaccines,"May lead to more effective and stable vaccines against bacterial infections, particularly those with capsular polysaccharides"
2017,https://doi.org/10.1021/acs.orglett.7b00945,Cyclitol analogue,Rhamnose,2a (n-Pr cyclitol diacetate),Designed to improve bioavailability and inhibit RSK1/2 activity.,"Potential anticancer agent due to improved RSK inhibition, which may suppress tumor growth and metastasis"
2017,https://doi.org/10.1021/acs.orglett.7b00945,Cyclitol analogue,Rhamnose,2b (C-3/C-4 bis-carbamate),Aimed at enhancing stability and RSK inhibition.,"Promising anticancer activity through RSK inhibition, potentially effective in treating various types of cancer"
2017,https://doi.org/10.1021/acs.orglett.7b00945,Carbasugar analogue,"Sugars in general, particularly rhamnose derivatives.",5a-carbasugar analogues,To explore structure-activity relationships and improve RSK1/2 inhibition.,Part of ongoing research to develop more effective anticancer treatments targeting RSK-mediated pathways
2017,https://doi.org/10.1021/acs.orglett.7b00945,Structural modification,Rhamnose (specifically the C-3 and C-4 positions),C-3/C-4-n-Pr-carbamates,To enhance the stability and efficacy of the analogues.,Potential improvement in anticancer activity through more stable and effective RSK inhibition
2018,https://doi.org/10.1002/ejoc.201701601,Glycosidase Inhibitors,Retaining β-glucopyranosides,Carba-cyclophellitol 4,Acts as a competitive inhibitor of retaining β-glucosidases.,Binds tightly to the enzyme active site in a 4H3 conformation and inhibits enzyme activity.
2018,https://doi.org/10.1002/ejoc.201701601,Glycosidase Inhibitors,Retaining β-glucopyranosides,Cyclophellitol Aziridine (2),Acts as an irreversible covalent inhibitor of retaining β-glucosidases.,"Inhibits enzyme by forming a covalent bond with the active site, rendering it inactive."
2018,https://doi.org/10.1002/ejoc.201701601,Glycosidase Inhibitors,α-glucopyranose and β-glucopyranose configured analogues,α-Carba-Cyclophellitol,Competitive inhibition of retaining β-glucosidases.,"Binds to the active site, preventing substrate binding and enzyme activity."
2018,https://doi.org/10.1002/ejoc.201701601,Glycosidase Inhibitors,α- and β-galactopyranose configured analogues,Carba-Cyclophellitol Derivatives ,Competitive inhibitors of retaining β-galactosidases.,"Bind to the enzyme's active site, competitively inhibiting substrate binding and enzymatic activity."
2018,https://doi.org/10.1002/chem.201705469,Glycomimetics (heparin-related),Natural heparin,Heparin-related glycopolymers,"These glycomimetics function as anticoagulants by modulating the interaction with antithrombin III, enhancing its ability to inhibit coagulation factors","The glycopolymers exhibit anticoagulant activity that can surpass that of natural heparin, demonstrating improved efficacy in blood coagulation inhibition"
2018,https://doi.org/10.1002/chem.201705470,Glycomimetics (Vi antigen),Natural Vi polysaccharides,"Tetra-methylene or 1,2,3-triazole-linked oligosaccharide mimetics of Vi antigen","These mimetics are designed to bind to anti-Vi antibodies, potentially serving as vaccine candidates against Salmonella typhi","The antigenic activity of these mimetics is comparable to that of the natural tetrasaccharide, indicating their potential in vaccine development, although they do not fully replicate the natural structure"
2018,https://doi.org/10.1002/chem.201705471,Glycomimetics (β-(1→3) glucan mimetics),Natural β-(1→3) glucans,Hydroxylamine-based di- and tri-oligomers of β-(1→3) glucans,"These mimetics are designed to bind to complement receptors and stimulate immune responses, such as phagocytosis","The biological results indicate that these glycomimetics can stimulate phagocytosis in a length-dependent manner, with the trimer mimetic showing significant activity"
2018,https://doi.org/10.1002/chem.201705472,"Glycomimetics (specifically, pseudo-oligosaccharides)","Natural tetrasaccharides, specifically fragments of the Vi antigen",Pseudo-octasaccharides linked by either tetramethylene or triazole,"These pseudo-octasaccharides are designed to mimic natural Vi oligosaccharides and compete for binding to anti-Vi antibodies, aiding in vaccine development","The competitive ELISA assay showed that the antigenic activity of the pseudo-octasaccharides is similar to that of the natural tetrasaccharide, providing a useful starting point for Vi-based vaccine discovery"
2018,https://doi.org/10.1016/j.aca.2018.08.025,Monosaccharide (Galactose),Galactose,Carbohydrate-mimetic peptide (YYYYC),"Mimics galactose residues to bind galactose-recognizing proteins such as SBA, facilitating detection of target proteins and cells with galactose-terminal carbohydrate chains.","Acts as an electron-transfer sensor in electrochemical assays; interacts specifically with galactose-binding proteins and receptors on cells, enabling label-free detection of cancer cells and proteins related to galactose-binding."
2018,https://doi.org/10.1016/j.aca.2018.08.026,"Monosaccharides (Galactose, N-acetylgalactosamine)",N-acetylgalactosamine and galactose,Peptides with YXY sequences (general class),"Serve as carbohydrate-mimetic units capable of binding to carbohydrate-binding proteins (lectins and galectins), enabling the recognition of specific glycan structures on cell surfaces or glycoproteins, especially those altered in cancer.","Function as probes in electrochemical sensing systems; facilitate interactions with target proteins and cells that display specific carbohydrate epitopes, aiding in disease diagnostics like cancer cell detection"
2018,https://doi.org/10.1016/j.aca.2017.11.047,"Monosaccharide (specifically, a hexose).",Methyl α-D-mannopyranoside,MYWYPY,Inhibits the binding of methyl α-D-mannopyranoside to concanavalin A (ConA),"Interacts with the protein at or near the carbohydrate binding site, acting as an inhibitor"
2018,https://doi.org/10.1016/j.aca.2017.11.048,"Monosaccharide (specifically, a hexose).",Methyl α-D-mannopyranoside,DVFYPYPYASGS,"Interacts with ConA, mimicking the binding of carbohydrate",Binding constant reported to be 2.2 × 10⁴ L/mol; suppresses ConA-induced T-cell proliferation
2018,https://doi.org/10.1016/j.aca.2017.11.049,tumor-associated glycoproteins or glycolipids,Not explicitly mentioned,IFLLWQR,Targets properties of annexin for tumor targeting,Demonstrates specific tumor-targeting activity and serves as a vehicle for anti-cancer drugs
2018,https://doi.org/10.1016/j.aca.2017.11.050,galactose,Not explicitly mentioned,YYYY-C and YYYYY-C,Functions as an electron-transfer agent and interacts with carbohydrate-binding proteins,Demonstrates electroactivity in the context of molecular recognition
2018,https://doi.org/10.1016/j.aca.2017.11.051,Monosaccharide,Galactose,"YXY (where X can be alanine, glutamic acid, threonine, or tyrosine)",Selectively interacts with several galactose recognition proteins,"Peptides containing the YXY sequence were designed to evaluate the interaction with galactose-binding proteins, showing selective binding"
2018,https://doi.org/10.1016/j.aca.2017.11.052,Peptidoglycan-derived carbohydrate,N-acetylglucosaminyl-β1-4-N-acetylmuramyl-alanyl-d-isoglutamine (GMDP),Peptide mimics of N-acetylglucosaminyl-β1-4-N-acetylmuramyl-alanyl-d-isoglutamine (GMDP),Demonstrated adjuvant activities,Induces immune responses through the production of anti-carbohydrate antibodies
2019,https://doi.org/10.3390/biomimetics4030053,Glycan,Neuraminic acid,Oseltamivir (Tamiflu),Antiviral drug used for the treatment and prophylaxis of influenza A and B.,"Inhibits neuraminidase, an enzyme on the surface of the influenza virus, which is essential for the virus's replication and spread."
2019,https://doi.org/10.3390/biomimetics4030054,Glycan,Neuraminic acid,Zanamivir (Relenza),Antiviral drug used for the treatment of influenza A and B.,"Inhibits neuraminidase, preventing the release of new viral particles from infected cells."
2019,https://doi.org/10.3390/biomimetics4030055,Glycan,Transition state of glycosidic bond hydrolysis,Iminoglycosides,Used to inhibit glycosidases by mimicking the transition state of the enzymatic reaction.,"Binds to the active site of glycosidases with high affinity, preventing the enzyme from catalyzing the hydrolysis of glycosidic bonds."
2019,https://doi.org/10.3390/biomimetics4030056,Glycosaminoglycan (GAG),Heparin,Heparin mimetics,Anticoagulant used to prevent blood clots.,"Mimics heparin by interacting with antithrombin, enhancing its ability to inhibit thrombin and other proteases involved in blood clotting."
2019,https://doi.org/10.3390/biomimetics4030057,Glycan,Multivalent carbohydrate structure,Multivalent glycomimetics,Used to enhance binding affinity through multivalent interactions.,"Binds to multiple sites on a target protein or cell surface, increasing overall binding strength and efficacy."
2019,https://www.tandfonline.com/doi/full/10.2147/IJN.S213455#d1e223,peptides,Annexin A1,motif IF-7 (IF-7-MNC),"To deliver the chemotherapeutics through the nanoparticles, the delivery system should accumulate at the tumor site first and then penetrate through the interstitium into the interior",enhancing tumor targeting and promoting the penetration of the drug delivery system into tumor tissues
2019,https://doi.org/10.1007/s11130-019-00723-z,Carbohydrate-based fat mimetics,"Fats (specifically, saturated fats in bakery products)",Inulin,Inulin serves to reduce fat content in bakery products while providing similar textural and mouthfeel properties to fats,"Inulin promotes the endogenous formation of 3-MCPDE during baking, particularly at higher concentrations, due to the formation of Maillard products."
2019,https://doi.org/10.1007/s11130-019-00723-z,Carbohydrate-based fat mimetics,"Fats (specifically, saturated fats in bakery products)",Pectin,Pectin serves to reduce fat content in bakery products while providing similar textural and mouthfeel properties to fats,"Pectin helps maintain lower levels of glycidyl esters during baking and storage due to its ability to bind water and create a stable gel matrix, which affects the thermal stability of these compounds."
2019,https://doi.org/10.3390/molecules24061004,Fucose-containing glycans,Fucosylated glycan structures,Rivipansel (GMI-1070),Acts as a glycomimetic inhibitor to block selectin-mediated cell adhesion,Reduces inflammation and improves outcomes in conditions like sickle cell disease.
2020,https://doi.org/10.1002/med.21625,Neisseria meningitides serogroup A capsular polysaccharide,"Manα(1,2)Man",Carbocyclic analogue (27),Designed to mimic the minimal natural epitope of dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin (DC-SIGN).,"Binds to pathogens such as HIV, Ebola, and Dengue viruses by recognizing glycosylated structures on their surfaces"
2020,https://doi.org/10.1002/med.21625,High-mannose glycan,"Manα(1,2)Man",Mannose-based glycomimetic antagonist (28),Mimics the natural epitope and improves metabolic stability.,Binds to DC-SIGN with low millimolar affinity​
2020,https://doi.org/10.1002/med.21625,High-mannose glycan,"Manα(1,2)Man",Carbamannose-based pseudodisaccharide (29),Similar to mannose-based glycomimetic antagonist (28) with enhanced affinity.,Binds to DC-SIGN with low millimolar affinity
2020,https://doi.org/10.1002/med.21625,High-mannose glycan,"Manα(1,2)Man",6-Amino derivative of pseudodisaccharide (32),Designed to selectively bind to DC-SIGN and not to Langerin.,Binds selectively to DC-SIGN and impairs binding to Langerin due to electrostatic repulsion​
2020,https://doi.org/10.1002/med.21625,Galactose,Galactose,Bicyclo[4.1.0]heptyl analogue (38),Mechanism-based covalent inhibitor of glycoside hydrolases.,Inactivates α-galactosidase by covalent binding at the enzyme's active site​
2020,https://doi.org/10.1002/med.21625,Galactose,Galactose,Fluorocarbasugar (39),Improved leaving-group ability and slowed hydrolysis of the covalent intermediate.,Inactivates α-galactosidase by covalent binding at the enzyme's active site​
2020,https://doi.org/10.1002/med.21625,Cyclophellitol,Cyclophellitol,Cyclopropyl analogue of cyclophellitol (45-47),Mechanism-based covalent inhibitors of glycoside hydrolases.,Inactivates glycoside hydrolases by covalent binding at the enzyme's active site
2020,https://doi.org/10.1002/ejoc.202001389,Azidopyran,3-Azidopyran,"Trivalent 1,2,3-Triazole-Linked Carbohydrate Mimetics (6-8)","Serve as multivalent ligands for biological targets, enhancing effects compared to monovalent ligands.","Used for their potential as L- and P-selectin ligands, showing promise in preliminary evaluations"
2020,https://doi.org/10.1002/ejoc.202001389,Azidopyran,3-Azidopyran,Unsymmetrical Trivalent Carbohydrate Mimetic (12),"Multivalent interaction with biological targets, potentially more effective due to asymmetry.","Evaluated as L- and P-selectin ligands, successfully O-sulfated to enhance activity​"
2020,https://doi.org/10.1002/ejoc.202001389,Azidopyran,3-Azidopyran,"Tetravalent 1,2,3-Triazole-Linked Carbohydrate Mimetic (16)",Multivalent ligands for enhancing biological interactions.,"Synthesized for evaluation as a ligand for selectins, showing good yield and potential"
2020,https://doi.org/10.1002/ejoc.202001389,Azidopyran,3-Azidopyran,"Hexavalent 1,2,3-Triazole-Linked Carbohydrate Mimetic (17)",Designed to enhance multivalent biological interactions.,"Evaluated as a selectin ligand, showing good reactivity and yield​"
2020,https://doi.org/10.1002/ejoc.202001389,Azidopyran,3-Azidopyran,"Octavalent 1,2,3-Triazole-Linked Carbohydrate Mimetic (18)","Provides multiple binding sites for biological targets, enhancing effectiveness.","Synthesized with good yield, evaluated for potential selectin binding​"
2020,https://doi.org/10.1002/ejoc.202001389,Azidopyran,3-Azidopyran,Dodecavalent C60-Fullerene Derived Carbohydrate Mimetic (22),Provides extensive multivalent interaction potential with biological targets.,"Preliminary SPR measurements indicate promising ligand activity for L- and P-selectins with low nanomolar IC50 values, successfully O-sulfated for enhanced activity​."
2022,https://doi.org/10.1039/D2CS00470D,Carbohydrate Mimetic Peptides (CMPs),Glycan,Glycan-mimetic peptide mimotopes,The regulation of glycan (carbohydrate)–protein interactions is needed to develop therapeutic strategies for glycan-related diseases,"modulate immune responses or inhibit glycan–protein interactions, serving as high-affinity ligands for lectins, inducing anti-glycan antibodies, or acting as vaccine candidates against pathogens and tumors"
2022,https://doi.org/10.1016/j.carres.2022.108697,synthetic polysaccharide mimetics,"Glycolipid biosurfactants (C14,C16,C18 terminal chain lengths)",Enantiopure poly-amido-saccharides (PASs),"These amphiphilic polymers are water soluble, adopt a helical secondary structure, decompose at temperatures greater than 240 °C, are non-cytotoxic, and self-assemble into nanostructures.","binding to carbohydrate-recognizing proteins (like lectins) and can act as highly effective protein stabilizers, offering enhanced stability and precise structural control compared to natural polysaccharides"
2023,https://doi.org/10.3390/molecules28072884,Tetrahydrofuran-containing acetogenins (THF-ACGs),Mannose,THF-ACG Mimetic 2,"Aimed at mimicking the structure of naturally occurring ACGs with the potential to disrupt mitochondrial ATP production, particularly in cancer cells.",Showed cytotoxicity in the low-to-submicromolar range against prostate cancer cell lines (PC-3 and LNCaP). Greater selectivity and potency were observed against PSMA receptor-positive LNCaP cells compared to receptor-negative PC-3 cells​
2023,https://doi.org/10.3390/molecules28072885,Tetrahydrofuran-containing acetogenins (THF-ACGs),Mannose,THF-ACG Mimetic 4,"Similar to Mimetic 2, designed to replace the more complex segments of naturally occurring ACGs with simpler, accessible substitutes.","Exhibited similar cytotoxicity profiles as Mimetic 2, with low-to-submicromolar cytotoxicity against PC-3 and LNCaP cells. More selective for LNCaP cells over PC-3, indicating potential for targeting prostate cancer cells with PSMA expression​"
2023,https://doi.org/10.1039/D2CS00954D,iminosugars,"biologically active carbohydrates uch as sialic acid, glucose, maltose, and other glycan epitopes-examples include oseltamivir (Tamiflu) ",Glycomimetic,Inhibition and modulation of lectins,"inhibit carbohydrate-processing enzymes or block lectin-mediated interactions, thereby modulating biological processes like viral infection, cancer metastasis"